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ABSTRACT 
 
Rpb9 is a conserved RNA polymerase II (pol II) subunit, the absence of which 
confers alterations to pol II enzymatic properties and transcription fidelity. It has been 
suggested previously that Rpb9 affects mobility of the trigger loop (TL), a structural 
element of Rpb1 that moves in and out of the active site with each elongation cycle. 
However, a biochemical mechanism for this effect has not been defined. We find that the 
mushroom toxin α-amanitin, which inhibits TL mobility, suppresses the effect of Rpb9 
on NTP misincorporation consistent with a role for Rpb9 in this process. Furthermore, 
we have identified missense alleles of RPB9 in yeast that suppress the severe growth 
defect caused by rpb1-G730D, a substitution within Rpb1 α-helix 21. These alleles 
suggest a model in which Rpb9 indirectly affects TL mobility by anchoring the position 
of α21, with which the TL directly interacts during opening and closing. Amino acid 
substitutions in Rpb9 or Rpb1 that disrupt proposed anchoring interactions resulted in 
phenotypes shared by rpb9∆ strains, including increased elongation rate in vitro. 
Combinations of rpb9∆ with the fast rpb1 alleles that we identified did not result in 
significantly faster in vitro misincorporation rates than those resulting from the RPB1 
mutations alone, and this epistasis is consistent with the idea that defects caused by the 
rpb1 alleles are related mechanistically to the defects caused by rpb9∆. We conclude 
that Rpb9 supports intra-pol II interactions that modulate TL function and thus pol II 
enzymatic properties, which distinguishes Rpb9 from its counterparts in pol I and III. In 
addition, we also find that several of the genetic interactions between RPB9 and genes 
 iii 
 
encoding components of chromatin modifying complexes are dependent on the first 11-
16 amino acids of the Rpb9 N-terminal domain. This same region also interacts with the 
transcription factor Bye1, and may be important for TFIIF association with pol II. This 
suggests that there are two distinct modes of Rpb9 function—one at the active site, and 
one on the exterior of pol II.  
iv 
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CHAPTER I 
INTRODUCTION  
 
From the discovery of the fundamental molecular structure of the gene in 1953 
by Watson and Crick (Watson and Crick, 1953), the interpretation and utilization of the 
information encoded and stored inside DNA has been sought. From the Central Dogma, 
we understand that DNA is made tractable through RNA, the functional message that is 
not only used to translate proteins, but also can be used in various other gene regulatory 
pathways as seen in gene down-regulation with interfering RNAs and gene processing 
with non-coding RNAs (for a review see (Jonas and Izaurralde, 2015; Morris and 
Mattick, 2014) ). The act of transcribing a RNA is a highly regulated process carried out 
by RNA polymerase (RNAP), with the regulation and complexity increasing as 
evolutionary diversity increases. RNAP provides the catalytic scaffold for the 
phosphodiester bond formation to occur between ribonucleotides as dictated by the DNA 
template strand, as well as serving as a landing pad for a myriad of regulatory factors 
that decide the outcome and final character of the RNA being transcribed. In eukaryotes, 
transcription is carried out by three different RNAPs termed RNA polymerase I, II, and 
III (pol I, II, and III), which is in contrast to the single RNAP utilized in prokaryotic 
RNA synthesis. Pol I is the polymerase responsible for transcribing the specialized, large 
ribosomal RNA transcripts rather than a protein-coding RNA, and interestingly, its 
activity accounts for more than half of all transcription in the cell. Pol II, in contrast, is 
responsible for transcribing the most diverse population of RNAs—the protein-coding 
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messenger RNAs. And finally, similar to pol I, pol III is also responsible for the 
transcription of specialized RNAs, specifically the 5S ribosomal RNA and the transfer 
RNAs.  It is interesting to point out that though these RNAPs transcribe very different 
products, they have many similarities in their structure, sharing 3 of the same subunits, 
and mechanistically as they all have three distinct phases (termed initiation, elongation, 
and termination) in the generation of their product RNAs.  
Of the three eukaryotic polymerases, pol II in particular has been the paradigm 
for studying the mechanism of transcription. Indeed, at the time of writing this work, of 
the peer-reviewed literature that exists on any of the three polymerases, ~89% is 
dedicated to pol II. This may not be particularly surprising with consideration of the fact 
that pol II is responsible for manufacturing the blueprints for virtually every molecular 
machine that exists in the cell, and that the timing, usage, and degradation of those 
blueprints are highly regulated. However, though much study had been devoted to 
understanding core structural, biochemical and regulatory mechanisms of pol II,  less is 
known about how pol II faithfully transcribes (approximately 1 mistake out of every 
100,000 bases) each of the protein blue prints from a DNA template. Maintenance of 
accurate mRNA transcription inside the cell is essential to life. Errors that occur during 
transcription can potentially lead to misfolded, truncated, or non-functional proteins that 
can have deleterious effects in the cell. Therefore, it is vital to understand the 
fundamental attributes and intrinsic, mechanistic accuracy that pol II utilizes to 
polymerize ribonucletides from a DNA template.  
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In this work, I focus on how structural elements of the budding yeast 
(Saccharomyces cerevisiae) pol II subunit Rpb9 can interact with and directly modulate 
the function of the pol II core catalytic domain termed the Trigger Loop (TL), which has 
been shown through various biochemical and genetic studies to affect the accuracy of 
transcription. In addition, I will describe some interactions of Rpb9 with non-polymerase 
complexes that relate to chromatin and the cellular response to stress. S. cerevisiae was 
used as the model organism for these studies in particular because it provides several 
advantages. Yeast pol II is homologous to all eukaryotic pol II both in sequence and 
structure. In addition, yeast provides a genetically tractable platform and can be grown in 
sufficient quantities to satisfy the demands of biochemical experiments, which have led 
to its extensive use in the study of various aspects of general pol II dynamics.     
 
RNA polymerase II introduction 
 
The first step in the utilization of genetic information is transcription of the DNA 
template to synthesize a complementary RNA. In eukaryotes, protein-coding genes are 
transcribed by RNA polymerase II, a complex and highly regulated process in which pol 
II transiently interacts with distinct sets of proteins during transcription initiation, 
elongation, and termination (Hampsey, 1998). Pol II in Saccharomyces cerevisiae 
consists of twelve subunits encoded by genes RPB1 through RPB12 (Woychik, 1994). 
Among eukaryotic pol II there is extensive structural homology. Indeed, so much 
homology that six subunits of human pol II can effectively replace their orthologous 
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counterparts in yeast (McKune, 1995). The Rpb1, Rpb2, Rpb3, Rpb4, Rpb7, Rpb9, and 
Rpb11 subunits of pol II have homologs in RNA pol I and III. An additional five 
subunits, Rpb5, Rpb6, Rpb8, Rpb10, and Rpb12 are shared by all three polymerases 
(Woychik, 1994; Woychik et al., 1990; Young, 1991). Rpb9 and Rpb4 are the only non-
essential subunits, though each confers a growth phenotype upon removal. The two 
largest subunits, Rpb1 and Rpb2 (β΄ and β in bacteria), which form the main body of the 
polymerase, are the most conserved. Rpb1 and Rpb2 are similar to their bacterial 
homologs not only in structure, but also in function, as Rpb1/β΄ is involved in DNA 
binding, and Rpb2/β is involved in nucleotide substrate binding. Such commonality in 
structure and function suggests a common mechanism for nucleotide addition between 
bacterial polymerase and pol II (Cramer, 2002).  
Several high–resolution crystal structures have been solved for yeast pol II that 
include bound templates, product RNA, and substrate NTPs. These structures have 
yielded much information about molecular contacts occurring within the polymerase 
during the process of transcription. Fig. 1.1 (left panel) depicts a crystal structure 
(Kettenberger, 2003) of 12 subunit pol II in an orientation known as the “top view.” A 
large part of the structure is made up of Rpb1 and Rpb2, in tan and green, respectively. 
They form the primary channel, which cradles the downstream DNA, entering on the 
right of the polymerase, and subsequently turning 90o at the active site where the 
template DNA (blue) is in complex with the growing RNA chain (red). Rotating the top 
view of the polymerase 180o (Fig. 1.1, right panel) exposes other features of the enzyme 
such as the “funnel” domain, which flanks the active site at the 90o turn of the template  
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Figure 1.1: Structure of 12 subunit RNA pol II from yeast 
 
Figure 2.1: Structure of 12 Subunit RNA pol II from Yeast 
Pictured is the crystal structure of 12 subunit, elongating RNA pol II (PDB code 
1Y1W). The structure seen in the first panel is positioned in the “top view.” 
Polymerase movement is from left to right on the template DNA (blue). Downstream 
DNA would extend out right from the polymerase; upstream DNA would extend out 
of the page. A portion of the nascent RNA transcript is pictured in red. The orange 
space-fill model is subunit Rpb9 located between Rpb1 and Rpb2 in tan and 
green respectively. The second panel is a clock-wise 180° rotation of the first panel, 
exposing the secondary channel of the polymerase which can be located by following 
the helical axis of the RNA/DNA hybrid out of the page. The “funnel” domain is to 
the left of the secondary channel which flanks the active site.   
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DNA and is proposed to be the path of incoming nucleotides (Kettenberger, 2003; 
Zhang, 1999). In the orange, space-fill representation is the Rpb9 subunit, which is 
located on the leading edge of the polymerase, and, along with Rpb1, forms a portion of 
the “jaw” and primary channel (Conaway, 2000). Most of the work reported here relates 
to the function of Rpb9.  
 Movement of pol II does not occur across the template DNA at a constant rate. 
Rather, the polymerase can pause, stop, and backtrack. The reasons underlying this 
attenuation are various, including physical barriers (Orphanides, 2000), damage to 
template DNA, and specific pause sites intrinsic to the template sequence (Bai, 2004). 
The most substantial of these hindrances is the presence of chromatin. Nucleosome 
blocks can be overcome through various mechanisms such as histone tail modifications 
(Roth, 2001), nucleosome remodeling via remodeling complexes like Swi/Snf and RSC 
(Liu, 2011), and the synergistic action of multiple polymerases on a template (Jin, 2011). 
In addition, transcriptional arrest can occur when pol II becomes stuck in a backtracked 
state. This may be remedied by the nuclease activity of pol II (Wang, 1993), which 
aligns a new 3′ end of the RNA with the catalytic center, leading to the continuation of 
transcription (Izban, 1993, 1992; Kulish, 2001; Reins, 1999). This nuclease activity is 
intrinsic to pol II; however, it is enhanced by the extrinsic transcription factor TFIIS, 
which distinguishes pol II from pol I and pol III, where efficient cleavage does not 
require an extrinsic protein (Izban, 1992; Kettenberger, 2003; Ruan, 2011). Extrinsic 
cleavage stimulation in yeast, as well as all eukaryotes, is thought to be a conserved trait 
from bacteria, where a protein orthologous to TFIIS (GreA in E. coli) is required 
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(Borukhov et al., 1993; Opalka et al., 2003). Several crystal structures of TFIIS in 
complex with pol II reveal that a C-terminal zinc ribbon domain of TFIIS enters through 
the funnel of pol II to contact the active site, where it is thought that acidic residues of 
TFIIS help to coordinate active site-bound Mg2+, changing the active site environment 
for nuclease activity (Fish and Kane, 2002; Kettenberger, 2003).  
 
 
Mechanism of RNA polymerase II catalysis 
 
 All DNA-dependent RNA polymerases have a commonality in that their first 
catalytic step is the transfer of a nucleotidy1-moeity from a matched substrate NTP to 
the 3′-hydroxyl group located on the ribose base of the ultimate nucleotide on the 
nascent RNA end. This requires not only that the active site of RNAP be spatially 
accommodating to a transcription bubble containing an RNA/DNA hybrid, but also must 
contain a binding site for the 3′-end of the nascent RNA and the incoming substrate. In 
addition, every round of phosphodiester bond synthesis must be accompanied with the 
forward progress of translocation of the polymerase from one position to the next. 
Extensive study of both bacterial RNAP and yeast RNA pol II crystal structures has 
identified specific conformation states that describes this progressive cycling referred to 
as the nucleotide addition cycle (NAC) (See Fig. 1.2A) (Martinez-Rucobo and Cramer, 
2013).  
The NAC begins with the polymerase in a post-translocated state. In this state the 
DNA template base that is immediately 5′ to the DNA base currently paired to the 3′  
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Illustrated in (A) is the nucleotide addition cycle modified from Martinez-Rucobo, 
F.W., and Cramer, P. (2013). Template DNA and nascent RNA is shown in blue and 
red respectively. The dashed line represents the position of the i+1 site or A-site. 
Active site magnesium ions are colored in magenta, with the incoming substrate 
nucleotide colored in orange. (B) Illustrates the two metal mechanism of catalysis for 
all RNAPs (Sosunov et al., 2003). Colored in blue is the substrate base and in green, 
the coordinated active site magnesium ions. The 3′-OH on the ribose base of the RNA 
3′ end nucleophilically attacks the α- phosphate of the substrate, evolving 
pyrophosphate.  
 
Figure 1.2: NAC and mechanism of catalysis of RNA pol II 
 
Figure 1.2: NAC and Mechanism of catalysis of RNA pol II 
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base of the nascent RNA transcript is free to be bound by the next correct nucleotide. 
The position on the DNA template that would correspond to the RNA chain being 
extended to i+1 nucleotides in length is referred to as the A, (i+1), or insertion site. It is 
at this point that correct or incorrect nucleotides approach the active site through the 
secondary or primary cleft of pol II and are selected for or against (Wang, 2006). Once a 
matched NTP is paired with the template in the insertion site, nucleotide addition can 
occur. The generally accepted two-metal ion catalytic mechanism illustrated in Fig. 1.2 
B is an SN2 mechanism facilitated by two Mg
2+  (colored in green and coordinated by 
conserved aspartate residues) and is accomplished through attack of the α-phosphate on 
the matched nucleotide by the 3′-OH group on the ribose base of 3′- most RNA 
nucleotide (Sosunov et al., 2003). The new phosphodiester bond formation is followed 
by pyrophosphate release with the polymerase in a pre-translocated state and the RNA 
3′-end occupying the insertion site. RNAP then translocates (pre- to post- translocated) 
freeing the insertion site for new round of nucleotide addition. Single molecule studies 
have suggested that the three stages of pol II elongation—substrate selection, 
translocation, and catalysis—are consistent with a ‘Brownian ratchet’ model. In this 
model, the substrate can bind either translocation state of pol II, and the actual transition 
from pre- and post-translocated state is governed by a mobile element at the active site 
termed the Trigger Loop, which will be discussed in later sections (Bar-Nahum et al., 
2005; Brueckner and Cramer, 2008; Gnatt et al., 2001). 
 In addition to the canonical A-site, high-resolution crystallographic studies have 
suggested multiple substrate binding sites that in some instances occupy some of the 
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same spatial area as the A-site (Kettenberger et al., 2004; Sosunov et al., 2003; Westover 
et al., 2004). One interpretation is that the process of substrate positioning within the 
active site is a multi-step, coordinated process that gives rise to intermediate 
conformations that could potentially be check points for fidelity (discussed further in 
later sections). The other alternative is that they represent non-native states that are 
synthetically caused by artifacts of pol II complexes assembled with unnatural 
substrates. However, these proposed sites observed in crystal structures of pol II do 
deserve scrutiny. One putative site was based on a crystal structure that was solved with 
a non-hydrolyzable substrate. Though the substrate was non-complementary, and the 
triphosphate of the analog was still coordinated with the active site magnesium 
molecules, the base was flipped facing away from the template DNA and occupying 
what was proposed as the E-site. This site was suggested to be important for a base 
discrimination check point during catalysis (Westover et al., 2004). Another site was 
suggested by a differing experimental approach using a different complementary NTP 
analog that was unable to be incorporated into the RNA chain. In this crystallographic 
study, the resulting elongation complex (EC) co-crystal suggested an alternative NTP 
pre-insertion site which largely overlaps the characterized A-site (Kettenberger et al., 
2004; Wang, 2006; Westover et al., 2004).  
The NAC in all RNA polymerases is dictated in part by two common, dynamic 
structural features—the Trigger Loop (TL), and the Bridge Helix (BH). These mobile 
domains have been implicated in various roles for nucleotide selection, binding, and the 
translocation step (Gnatt et al., 2001; Larson et al., 2012; Toulokhonov et al., 2007; 
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Vassylyev, 2007; Wang, 2006). The TL is a highly mobile domain in the active site and 
has been studied in essentially two main conformations within the crystal structure—the 
‘closed’ state and the ‘open’ state. The closed state is characterized as the state in which 
the TL is closed down on the active site trapping the substrate at the A-site and 
providing acidic residues for catalysis (Kaplan, 2008; Vassylyev, 2007; Wang, 2006). In 
addition, it is thought that in the closed state the TL, in conjunction with the BH, work 
together to facilitate substrate binding and selection through a complex coordination of 
the ribose sugar, base, and triphosphate group (Kaplan, 2008; Kireeva et al., 2008; 
Larson et al., 2012; Vassylyev, 2007). This ensures that a matched substrate has bound 
at the A-site allowing for the closing and folding of the TL on the active site, which 
sequesters the substrate and provides an optimal conformation for catalysis and accurate 
transcription. The sequestration of the active-site-bound NTP and exclusion of other 
substrates by the closed state of the TL have also been observed with EDTA-quenching, 
which identified EDTA-resistant and sensitive pol II conformations, again suggesting a 
closed and open state (Kireeva et al., 2008; Walmacq et al., 2009). The ‘open’ 
conformation of the TL allows for the NTP to enter and bind the active site, potentially 
at the pre-insertion site. The substrate NTP has been proposed to approach the active site 
either through the secondary pore flanking the active site, or alternatively through the 
main cleft. However, there is some debate over which one is the actual pathway (Batada 
et al., 2004; Burton et al., 2005). If the substrate NTP base-pairs appropriately with the 
DNA at the A-site, the TL can then transition to the closed state. The open state of the 
TL is also important for the extrinsic factor TFIIS to gain access to the active site. TFIIS 
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is a cleavage factor that is critical for rescuing pol II when it becomes arrested or is in a 
back-tracked state due to DNA damage, mistakes in the RNA, or encounters with 
nucleosomes, as will be discussed in later sections. Much biochemical, genetic, and 
computational study has been devoted to understanding the transition of the TL between 
its various states. The obvious implication of the mobility of the TL is that changing the 
rate at which the TL is in or out of the active site affects not only the rate of 
transcription, but also its accuracy.  
As seen in Fig. 1.2, the NAC is also dependent on the translocation state of the 
polymerase. The elongating polymerase is constantly shifting between a post-
translocated (competent for elongation, exposed A-site), pre-translocated (occupied A-
site, inactive), and backtracked states. In addition to their roles in selection and catalysis, 
the TL and BH also play a role in shifting through these various translocation states, 
which appears to be independent of NTP hydrolysis (Fig. 1.3) (Abbondanzieri et al., 
2005; Bar-Nahum et al., 2005; Brueckner and Cramer, 2008; Larson et al., 2012).  The 
current model for understanding the translocation process is a combination of two 
previously described models. The first model was proposed based on several crystal 
structures of both yeast and bacterial RNAPs in which the bending of the BH after NTP 
incorporation at the A-site provided the motive force to move the RNAP position by one 
nucleotide. That is, that the BH acts as a reciprocating claw that aligns the RNAP off of 
the incoming NTP at the active site, causing the shift between pre- and post-translocated 
states with the TL playing a supplementa  l coordinating role (Gnatt et al., 2001). The 
alternate model proposes that the TL, as opposed to the BH, plays the major role in  
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Above is a rendering of the relative positions of the TL (purple) and BH (green) in 
relation to the RNA end (red) at the active center pol II (modified from (Kireeva et al., 
2012; Wang, 2006)). Lines between residues indicate interaction pairs. Bottom panel 
shows the stages of opening and closing of the TL and movement of the BH during 
the NAC. See text for more details.  
  
Figure 1.3: Trigger Loop/Bridge Helix active site location and movement during 
NAC 
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translocation (Toulokhonov et al., 2007; Vassylyev, 2007). The model proposed that 
lateral movement of the RNAP is restricted upon the binding of a matched substrate. The 
subsequent folding of the TL on the active site further stabilizes the bound NTP, 
favoring the forward movement of the RNAP by preventing backtracking. However, this 
model does not explain the effects of the TL on RNAP translocation state independent of 
substrate (Bar-Nahum et al., 2005). In reality the translocation mechanism is most likely 
a combination of both models, such that the TL and BH act in concert by actively 
blocking backtracking, and favoring forward translocation (Brueckner and Cramer, 
2008). Single-molecule studies with mutations in the TL of yeast pol II are in agreement 
with this. The closure of the TL on the bound NTP inhibits translocation. This can be 
exacerbated by an amino acid substitution in the TL (Rpb1-E1103G) that affects 
movement of the TL between different conformations, causing the TL to prefer the pre-
translocated state (Larson et al., 2012). However, it is thought that after incorporation 
into the 3′-end of the RNA, translocation is allowed by the opening of the TL along with 
conformation changes in the BH via a two-ratchet mechanism (Fig. 1.3 bottom panel) 
(Burton et al., 2005; Kireeva et al., 2012). It’s clear from the current interpretation of the 
NAC based on structural and biochemical data, that the TL plays a central role in both 
translocation, and as discussed in the next section, transcriptional fidelity.  
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RNA polymerase II Fidelity  
 
The accurate production of a transcript by pol II is important at all levels of 
cellular function. Erroneous transcription can lead to non-functional, truncated, and mis-
folded proteins that manifest themselves in deleterious ways across the cell (Saxowsky, 
2006; van Leeuwen et al., 2000). Two basic processes determine how RNA polymerases 
maintain faithful transcription: (a) the stringent selection of substrate, and (b) 
recognition and removal of an error. Within pol II, the mobile TL domain plays a critical 
role in these processes, and can be affected through altering its ability to transition in and 
out of the active site.  
 
Selectivity and Trigger Loop mobility 
  
  The first step in maintaining accurate transcription in pol II is the selection of the 
correct, matched, template-specified nucleotide. The selectivity of pol II refers to the 
ability of the polymerase to differentiate between ribonucleotides as well as deoxy-
ribonucleotides that may be complementary to the template (for a review see (Brueckner, 
2009)). The incoming NTP enters the open polymerase active site and binds to an 
insertion site. At this site, the DNA template is exposed establishing the Watson-Crick 
base pairing for the incoming nucleotide. The mobile TL then folds down on the active 
site and catalysis occurs. This mobile element, as well as some surrounding residues, 
have been implicated in transcriptional fidelity (for review see (Kaplan, 2010)). From 
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various crystallographic studies it has been shown that the TL takes on a stable 
conformation, making contacts with the substrate, when the correct NTP is in position to 
be added to the RNA chain. The TL in this conformation at the active center is proposed 
to promote catalysis through a histidine residue (Rpb1-H1085) (Wang, 2006). Analysis 
of mutations within the TL have implicated several residues that are important for 
fidelity. Mutation of residue E1103, affecting the hinging of the TL around residue 
G1097, has been shown to significantly increase the rate of pol II misincorporation by 
affecting the movement of the loop, as have other mutations that occur in the same 
structural area such as Rpb1-L1101S and G1097D  (See Fig. 1.4) (Kaplan et al., 2012). 
It has also been demonstrated that a highly conserved histidine (H1085) is important for 
the discrimination of incorrect NTPs and matched 2’-dGTP. Other mutations in the TL 
vary in their effects on transcription. Mutations have been identified that increase 
(E1103G) or decrease (H1085Y) the incorporation of all nucleotide substrates or 
selectively affect only incorrect substrates (Kaplan, 2008). This suggests that the TL has 
dual roles in transcription, both in selection of substrate and promotion of efficient 
catalysis. Single molecule and computational analysis is also consistent with an effect of 
the TL on fidelity and speed (Kireeva et al., 2012; Larson et al., 2012; Wang et al., 2015; 
Wang et al., 2013). Specifically, the E1103G mutation has been shown to increase the 
observed catalytic rate, but also to increase the binding affinity of NTPs in general 
(Larson et al., 2012). Interestingly, in the same study, combination of E1103G with a 
mutation in H1085, which is important for catalysis and stabilization of the closed TL, 
reverts pol II to near wild-type function for translocation and substrate binding, but not  
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Figure 1.4: Key structural elements of the open and closed TL 
The panels on the left represent the relative positions of the amino acids in the closed (top) and 
open (bottom) conformations of the TL from the crystal structures on the right (PDB: 2E2H 
and 1Y1V). Also indicated are the hinging areas and the nucleotide interaction regions, as well 
as the relative location of the active site. Highlighted in yellow are residues H1085 which has 
been shown to be critical for catalysis, and E1103 which is thought to be important for TL 
mobility. Black arrows indicate the direction of movement for the TL.  
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for catalytic rate. This suggests that TL conformations that support substrate binding and 
translocation are separable from those necessary for catalysis.  
 Other residues surrounding the TL have also been proposed to participate in 
substrate selection, such as Rpb1-N479, which has counterparts in prokaryotic 
polymerases. In the closed TL structure N479 resides opposite to TL residue Q1078, 
which makes contacts with the triphosphate group of the incoming nucleotide (Sydow, 
2009b; Wang, 2006). The ability of pol II to distinguish between NTPs and dNTPs is 
based on interactions between the 2’-OH (Kettenberger, 2003) or 3′-O of the ribose base 
of the incoming nucleotide (Wang, 2006). Mutation of the N469 to a serine resulted in a 
reduction in differentiation between NTPs and dNTPs and was attributed to the loss of 
the contact between the 3′-OH of the ribose base (Wang, 2006), which is consistent with 
proposed mechanisms for the corresponding residues in T. thermophilis and E. coli 
(Svetlov, 2004; Vassylyev, 2007).  
 There are two factors that affect the selectivity of RNAPs. One is the overall 
catalytic efficiency for any given substrate, and the other is the propensity of the RNAP 
to bind a given substrate. Given that the dynamics of the TL of pol II affect both of these 
aspects based on mutational analysis and single molecule experimentation (Kireeva et 
al., 2012; Larson et al., 2012; Wang et al., 2015; Wang et al., 2013), it is important to 
understand the structural elements within pol II that govern the transition of the TL 
through its various states between open and closed. A mutation in the TL of pol II from 
yeast, Rpb1-E1103G has been commonly studied as a paradigm for the affect 
perturbations on TL mobility on pol II activity. Through computer modeling, in vitro 
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transcription assays, and stop-flow kinetics, The E1103G mutation has been shown to 
increase sequestration of substrate NTPs at the active site both for correct and incorrect 
NTPs (Walmacq et al., 2009). E1103G resides in a portion of the TL that ‘hinges’ based 
on whether the TL is in the open or closed conformation (Refer to Fig. 1.4). Systematic 
mutational analysis of the C-terminal hinge area where E1103 resides has been 
consistent in that mutations in the same area such as L1101S and G1097D increase the 
overall elongation rate, similar to E1103G (Kaplan et al., 2012). These mutations 
presumably stabilize the closed conformation of the TL such that the likelihood of pol II 
to incorporate any substrate is increased. Interestingly, this increase in pol II activity has 
been associated with changes in pol II start-site selection. It has been suggested that 
during initiation, a catalytically more active polymerase will be more likely to overcome 
the initial energy barrier of synthesis of ~5 nucleotides and will be more likely to start 
from an upstream start site (Braberg et al., 2013; Jin and Kaplan, 2015; Kaplan et al., 
2012). The opposite is true for mutations in the nucleotide interacting region (NIR) of 
the TL, which contains residues important for positioning the substrate base at the A-
site, stabilizing the closed TL, and catalysis. Mutations in this region of the TL (such as 
H1085Y and N1082S) generally are transcriptionally slow and utilize downstream sites 
more frequently (Kaplan et al., 2012b). Intriguingly, combinations of mutations, fast and 
slow, within the TL can mutually suppress the phenotypes of either single mutant 
(Kaplan et al., 2012).  
 In addition to intrinsic TL mutations, other mutations and subunits of the 
polymerase have been suggested to affect the movement of the TL in and out of the 
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active site. One study in particular modeled various transitions of the TL moving from 
the open to closed conformation using known crystal structures as a guide (Wang et al., 
2015). Using crystal structures of pol II, as well as RNAPs of T. thermophilus and E. 
coli, this study identified conserved residues that would be important for the stabilization 
of the various TL states. TL residues E1103 and K1092 and the non-TL residue D1309 
were identified as important for stabilizing the ‘open’ conformation of the TL. 
Interestingly, residues K1092 and its interacting partner E712 were proposed to form a 
salt bridge that affects one of the transition states of the TL. E712 resides near a loop 
connecting two α-helices in the ‘funnel’ domain of pol II, proximal to the C-terminal 
domain of the pol II subunit Rpb9 (See Fig. 1.5). Curiously, Rpb9 has been proposed to 
affect TL movement similar to the E1103 residue in the TL, though no direct molecular 
evidence has been provided (Walmacq et al., 2009). Nevertheless, it is clear from the 
literature that understanding how the TL transitions in and out of the active site is vital in 
our understanding of how pol II maintains a homeostatic speed that is efficient in 
meeting cellular demands but, provides enough time during the NAC to allow for 
fidelity check points either through base selection by the TL or through pol II 
proofreading mechanisms discussed in the next section.      
     
Proofreading 
 
  Despite selectivity mechanisms that minimize incorporation of an incorrectly 
templated base, errors do occur in the course of transcription. Pol II must be able to  
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Figure 1.5: Local structural environment of open TL 
 
Figure 3.1: Local structural enviroment of open TL 
Above is a rendering of a crystal structure (PDB: 1Y1V) showing the open 
conformation of the TL (green) and its proximity to the Rpb9 C-terminal domain 
(orange) and a loop connecting helices α- 20/-21 (grey) which forms part of the 
Funnel domain of pol II in yeast. See text for more details.  
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detect the error, slow transcription to allow for proofreading, and remove the mistake. 
Pol II incorporates incorrect substrates with varying efficiencies depending on sequence 
context and, regardless of the type of misincorporation, extension of the mismatch is 
slow (Sydow, 2009a). Mismatches can cause the polymerase to stall as a result of 
disrupting the competent active center conformation (Erie, 1993), which is attributed to 
the “frayed,” mismatched end of the RNA occupying the site where an incoming 
nucleotide would bind (Sydow, 2009a). The distortion caused by a misincorporated 
nucleotide at the 3′-end of the RNA can cause pol II to pause and subsequently enter into 
a backtracked state. The backtracking of the pol II moves the frayed end of the RNA to 
another defined site in the pol II active center known as the P- (proofreading) site 
(Martinez-Rucobo and Cramer, 2013). In order to resume productive transcription, pol II 
must remove the misincorporated nucleotide from the nascent RNA and realign the 3′-
end of the transcript with the active site. Pol II corrects its mistakes via an intrinsic 
nuclease activity, which can be stimulated by TFIIS, though the TFIIS stimulated 
cleavage is much more efficient than the intrinsic nuclease activity of pol II (Sigurdsson 
et al., 2010). Cleavage of a mismatch yields a new 3′-OH group at the end of the 
transcript that allows for RNA synthesis to continue. Removal of a mismatch occurs in 
dinucleotide steps, which removes both the terminal mismatch and the preceding 
nucleotide (Thomas, 1998). In order for this cleavage to take place, the polymerase must 
align the phosphodiester bond that will be cleaved with the active site by back-tracking 
such that the mismatched nucleotide moves from the (+1) to (+2) nucleotide position at 
the active site. TFIIS-mediated cleavage is then coordinated by the binding of TFIIS 
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through its pol II binding domain (domain II) to the “jaw” of pol II, followed by the 
insertion of domain III of TFIIS displacing the TL as demonstrated by the co-crystal of 
TFIIS bound with pol II (Kettenberger et al., 2004). Domain III of TFIIS has two acidic 
residues (D290 and E291 in S. cerevisiae) that are required the dinucleotide cleavage or 
a mismatched frayed RNA end, or the cleavage of a backtracked RNA.  
Though TFIIS clearly increases fidelity in vitro by enhancing proofreading, in 
vivo fidelity assays have yielded conflicting results (Nesser et al., 2006; Shaw et al., 
2002). In vitro, mutation of Domain III of TFIIS, which includes the acidic residues 
required for transcript cleavage completely abrogates cleavage activity (Sigurdsson et 
al., 2010) It is interesting to note that single molecule experiments have shown that 
TFIIS can suppress pausing and backtracks induced by mechanical or nucleosomal 
barriers by decreasing their lifetime  (Ishibashi et al., 2014; Schweikhard et al., 2014), 
and at least some of this activity seems to operate by a cleavage-independent 
mechanism. In addition, absence of the pol II subunit Rpb9 increases the rate of 
nucleotide addition to a RNA with a mismatched nucleotide at its 3′-end or immediately 
adjacent to its 3'-end and decreases the efficiency of TFIIS-mediated cleavage, 
decreasing the likelihood that transcription errors will be excised (Knippa and Peterson, 
2013). It would interesting to know whether transcriptionally fast mutations in the TL or 
the absence of Rpb9 increase competition with TFIIS for occupancy of the active site, as 
has been proposed in the bacterial system (Dangkulwanich et al., 2014; Roghanian et al., 
2011). II fidelity. 
A simple but useful fidelity model that incorporates pol II selectivity and 
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Normal transcription occurs via the various steps of the NAC which requires correct 
NTP selection, addition, and pol II translocation. If initial fidelity checkpoints fail and 
a misincorporation event occurs, it results in a frayed RNA 3′ end. This may 
subsequently result in a paused elongation complex (EC) which can result in 
backtracking of pol II. In order to remove the misincorporation and rescue the 
backtracked pol II complex (Proofreading), TFIIS is recruited to pol II which 
stimulates cleavage of a dinucleotide from the frayed RNA 3′ end which allows 
transcription to begin again. Backtracking that occurs independent of transcription 
errors is similarly reactivated by TFIIS mediated cleavage (adapted from Martinez-
Rucobo, F.W., and Cramer, P. (2013)).   
Figure 1.6: Integrated model for NAC, proofreading, and backtracking 
 
Figure 1.6: Integrated model for NAC, proofreading, and backtracking 
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proofreading is shown in Fig. 1.6 (Martinez-Rucobo and Cramer, 2013). Pol II with a 
transcript (i) nucleotides in length can be extended by either a correct nucleotide to a 
transcript (i+1) nucleotides long, or by an incorrect nucleotide to a transcript (i* +1) 
nucleotides long. In the first path the correct nucleotide is added, which results in 
accurate transcription, demonstrated by the left, NAC panel. The second path illustrates 
how an incorrect nucleotide is added to the 3′-end of the RNA chain, resulting in a 
mismatch with the template DNA and backtracking. Selectivity can be described as the 
ratio of the rates of incorporation of correct and incorrect NTPs, while transcriptional 
proofreading depends on the ratio of the rates of mismatch extension and removal. The 
product of these ratios defines fidelity in a quantitative way. For pol II, incorporation of 
an incorrect nucleotide occurs at a rate anywhere from 500 to 4000 times slower than the 
incorporation of a correct nucleotide (Kaplan, 2008; Thomas, 1998). After a 
misincorporation event, the rate of extension slows dramatically (Knippa and Peterson, 
2013; Thomas, 1998), providing a window that allows for removal of the incorrect 
nucleotide. Fig. 1.6 also illustrates that backtracking can occur due transcriptional arrest 
of pol II caused by long-term pausing or blocks to transcription such as nucleosomal 
barriers. An arrested pol II complex can be rescued by cleavage of the nascent RNA 
yielding a new, aligned 3′-end from which pol II can resume productive transcription.  
 
The RNA polymerase II subunit Rpb9 
 
Rpb9, a small 122 amino acid protein located on the leading edge of pol II, is 
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highly conserved among eukaryotes. In fact, the human homolog of Rpb9 can suppress 
the growth defect associated with the loss of Rpb9 in yeast (McKune et al., 1995). 
Indeed, the conservation of Rpb9 is not limited to pol II, as Rpb9 homologs A12.2 and 
C11 are present in pol I and III, respectively. Structurally, Rpb9 consists of three 
separate domains, two zinc-ribbon folds that are connected by a linker that forms a β 
motif with β28 of Rpb1 (Fig. 1.7). Zn1 and Zn2 each contain 2 cysteines (colored green) 
that coordinate Zn2+ (colored red) with a sequence context of CX2CXnCX2C. The C-
terminal zinc-ribbon fold (Zn2) is buried between the Rpb1 funnel domain and the lobe 
domain of Rpb2 (Fig. 1.1). The N- terminal domain (Zn1) extends from the main body 
of the polymerase, and, along with Rpb1, helps form part of the “jaw” that cradles the 
incoming DNA. The zinc-ribbon fold domain is not unique to Rpb9, but is a feature 
shared with various transcriptionally related proteins such as TFIIB and TFIIS. 
Interestingly, the C-terminal zinc-ribbon motif of TFIIS is shared with Rpb9’s 
counterparts in pol I and pol III. Furthermore, it has been demonstrated that substituting 
the C-terminal domain of Rpb9 with the C-terminal domain from pol III subunit C11, 
which is the domain of C11 responsible for stimulating nucleolytic cleavage, conveys a 
strong cleavage activity to pol II. This suggests that the system that pol II utilizes for 
transcript cleavage diverged during its evolution allowing for a remote system of 
cleavage stimulation while maintaining Rpb9 and its function in transcription (Ruan, 
2011).  
In vivo assays in budding yeast have suggested roles for Rpb9 in transcriptional 
fidelity. This was done through several assays that assessed fidelity in vivo by examining 
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Residues 91-94 
Figure 1.7: The RNA pol II subunit Rpb9 
 
Figure 1.7: The RNA pol II subunit Rpb9 
The secondary structure and protein sequence of Rpb9.  Zinc-ribbon fold domains are 
indicated by Zn1 or Zn2 in the structure, and highlighted in yellow in the protein 
sequence. Cysteines chelating the zinc atoms (red) are shown in green on the structure 
and highlighted in green in the sequence. Residues that are nearest the active site in pol 
II on a C-terminal loop of Rpb9 are indicated. The relative position of the Rpb9 
structure is the same as depicted in Fig 1.1. (PDB file 1Y1W) 
 
The secondary structure and protein sequence of Rpb9.  Zinc-ribbon fold domains are 
indicated by Zn1 or Zn2 in the structure, and highlighted in yellow in the protein 
sequence. Cysteines chelating the zinc atoms (red) are shown in green on the structure 
and highlighted in green in the sequence. Residues that are nearest the active site in pol 
II on a C-terminal loop of Rpb9 are indicated. The relative position of the Rpb9 
structure is the same as depicted in figure 1.  
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misincorporation-based correction of a stop codon inserted into a reporter gene 
demonstrated that reporter gene expression increased when RPB9 was deleted (Koyama, 
2007; Nesser et al., 2006). This correlates well with phenotypes of strains lacking Rpb9 
such as hypersensitivity to oxidative stress induced by menadione, which potentially 
leads to a need for increased discrimination or proofreading of oxidized nucleotides 
(Koyama, 2007). This is also consistent with in vitro observations that the absence of 
Rpb9 enhances error propagation and decreases the efficiency of TFIIS-mediated 
proofreading  (Knippa and Peterson, 2013). A study that employed rapid-quench kinetics 
(Walmacq et al., 2009a) showed that the lack of Rpb9 promotes increased sequestration 
of substrate NTP at the active site, suggesting that one function of Rpb9 is to delay 
closure of the TL. It was proposed that TL mobility is restrained through interaction with 
K93 of Rpb9 (see Figs. 1.5 and 1.7), but mutations in K93 did not provide evidence for 
this idea. This study also reported evidence for an effect of Rpb9 on substrate selectivity, 
but these results were not confirmed in work from our lab (Knippa and Peterson, 2013).    
In addition to a synthetic lethal interaction with the TL mutation rpb1-Ell03G 
(described previously), rpb9Δ also has genetic interactions with other mutations in pol II. 
Sit (suppressor of initiation of transcription) mutations were first isolated by Arndt et al. 
(Arndt et al., 1989) through a genetic screen that identified mutations that increased 
transcription of HIS4 in the absence of activating transcription factors normally required 
in wild type cells. Interestingly, these mutations, sit1 or sit2, were shown to be clustered 
in RPB1 and RPB2, encoding the two largest subunits of RNA pol II. Further analysis 
revealed that sit1 mutations cluster in 3 conserved regions of Rpb1: Region D, which 
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contains amino acids important for magnesium coordination in the active site; Region F, 
which is a portion of Rpb1 that not only interacts with Rpb9, but also forms part of the 
“funnel” domain of pol II; and Region G, which contains the TL (Archambault et al., 
1998). Much more recently, one of the sit1 mutants (sit 1-7 or rpb1-G730D) was re-
isolated in a screen for mutations that suppress oxidative stress in yeast (Koyama et al., 
2010). rpb1-G730D also caused suppression of many of the phenotypes associated with 
rpb9Δ strains (Koyama, 2007; Koyama et al., 2010). 
Besides its interactions with many mutations of pol II, RPB9 also has various 
interactions with non-polymerase genes (See Table 4.1). These genes serve various 
roles. Deletion of genes encoding proteins belonging to the SAGA (ADA2, GCN5, 
SPT3/7 ) and Paf1C complexes, which are important for pol II promoter escape and 
elongation, have been shown to be synthetic lethal with rpb9Δ, as have various alleles of 
the Mediator, Elongator, and basal initiation factors. To date, no satisfactory molecular 
interpretation has been given for the interactions of these distinct complex components 
and RPB9.  
 Rpb9 has been implicated as a key participant in processes beyond its roles in 
elongation and transcriptional fidelity, including transcription start site selection (Awrey, 
1997) and transcription-coupled repair (Li et al., 2006), one of the two specialized 
branches of nucleotide excision repair pathway. Transcription-coupled repair (TCR) 
occurs when pol II encounters DNA damage, such as pyrimidine dimers caused by UV 
light. At this point the polymerase stalls, which is a signal for the recruitment of various 
DNA repair factors to the actively transcribing gene (for a review see (Mullenders, 
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2015)).  During long-term stalling, Rpb9 has been shown to promote Rpb1 
ubiquitylation and degradation, independent of TCR. Interestingly, the promotion of 
Rpb1 degradation has been localized to the Zn2 domain, and TCR functions of Rpb9 are 
unaffected by the loss of Zn2 (Chen et al., 2007) which suggest that Rpb9’s TCR 
functions reside in the Zn1 domain and are independent of its function in Rpb1 
degradation.    
 
Functional differences and similarities in pol I and III 
 
In addition to the wealth of structural information gained from crystallographic 
studies of pol I and II (as well as a 17 Å EM pol III structure), a recent study 
(Viktorovskaya et al., 2013) that generated chimeric pol II enzymes with substitutions of 
the pol II TL and BH with their pol I and pol III counterparts, has provided insight into 
the similarities and differences between RNA pol active sites (recent pol I structure 
(Fernandez-Tornero et al., 2013) and review of pol II and III structures (Cramer et al., 
2008) ). In every case the substitutions allowed growth. However, the pol II enzyme 
containing the pol I TL did exhibit a growth defect, and, in some instances, analogous 
mutations in active site functional domains do not behave the same way in the three 
polymerases. For example, a mutation in the pol I TL (rpa190-E1224G), which 
corresponds to the well-studied rpb1-E1103G mutation in the pol II TL, had opposite 
effects. While rpb1-E1103G negatively affects translocation and yet increases the 
overall transcription rate of pol II, rpa190-E1224G decreases the rate of transcription 
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and increases pol I pausing (Viktorovskaya et al., 2013). The results with pol I, though 
opposite to what was expected (transcriptionally slow, as opposed to pol II E1103G 
(which is transcriptionally fast), were interpreted as still likely affecting the TL mobility. 
It was proposed that any increase in elongation rate due to the E1224G mutation might 
be masked by a limiting defect in translocation (Viktorovskaya et al., 2013).  
One of the most interesting mechanistic differences among the three eukaryotic 
polymerases is the way they proofread their mistakes. Compared to pol I and III, pol II 
has minimal intrinsic cleavage activity and requires the extrinsic factor TFIIS to 
stimulate cleavage of nucleotides from an RNA end. This lack of strong intrinsic 
cleavage activity is observed in vitro with transcription assays with purified pol II that 
measure the rate of misincorporation, which can be exacerbated by the lack of Rpb9 or 
the presence of the E1103G mutation in the TL (Knippa and Peterson, 2013; Walmacq et 
al., 2009). However, with pol I and III, there is no observable rate of misincorporation in 
vitro, even with the addition of the analogous E1103G mutation in the pol I TL 
(Viktorovskaya et al., 2013). This is due to the fact that the Rpb9 homologs of pol I and 
III, A12 and C11 respectively, have a C-terminal domain more closely related to TFIIS 
domain III, which can gain access to the active site directly and strongly stimulate 
cleavage, unlike the C-terminal domain of Rpb9 (Alic et al., 2007; Kuhn et al., 2007). 
However, it should be noted that Rpb9 is important for TFIIS mediated cleavage 
(Knippa and Peterson, 2013; Koyama, 2007; Koyama et al., 2010; Nesser et al., 2006). 
Not surprisingly, both the pol II mutation E1103G as well as its counterpart in pol I 
(E1124G) are synthetic lethal with the loss of Rpb9 or A12 (Viktorovskaya et al., 2013; 
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Walmacq et al., 2009). The E1103G mutation is also synthetic lethal with deletion of the 
gene encoding TFIIS, suggesting that the synthetic lethality resulting from the 
combination of E1103G and rpb9Δ is derived from a similar mechanism as its 
counterparts in pol I and III (Malagon et al., 2006).  
It is interesting to speculate on why enzymes that have high sequence identity at 
their active sites (43% between pol I, II, and III TLs) should have such different 
mechanisms for dealing with transcription errors. For pol I, it is possible that having a 
strong intrinsic cleavage activity is critical because of its high initiation rate and fast 
elongation (twice that of pol II (Mason and Struhl, 2005; Turowski and Tollervey, 
2015)). If pol I is paused on an rDNA template with a high polymerase density, it would 
be advantageous to have an intrinsic ability to overcome pauses rather than a remote 
system comparable to TFIIS recruitment. For pol III, not only is its strong intrinsic 
cleavage important for the proofreading response, but it is also important for 
termination, though a lack of a high resolution crystal structure limits more detailed 
investigation of the active site structural differences among the polymerases (Cramer et 
al., 2008). In the case of pol II, the variety of promoters, templates, and chromatin states 
it might encounter may demand an ability to have a multi-layered situational response. 
For instance, TFIIS, in addition to its role at the pol II active site, has been implicated in 
a role with the chromatin modifying SAGA complex, as well as with the Mediator 
complex, which binds upstream activating sequences in some pol II promoters and helps 
to coordinate pre-initiation complex formation (Wery et al., 2004). However, it should 
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be emphasized that all three polymerases still maintain a dependence on the TL and BH 
domains, as well as a necessity for cleavage activity, despite their template differences. 
Structural conservation can also be observed in peripheral sub-complexes of each 
of the three polymerases. For example, pol I and III contain a homologous pol II Rpb4/7 
sub-complex, but there is little sequence conservation for these heterodimers (Cramer et 
al., 2008). In pol II this complex, which can dissociate from the body of the polymerase 
and shuttle between the nucleus and cystoplasm, has been implicated in mRNA decay, as 
well as translation initiation (Duan et al., 2013). In the other two polymerases, these 
complexes have been suggested to be more important for interactions with initiation 
factors that are class-specific (Cramer et al., 2008). In addition, there is evidence that 
both pol I and pol III have TFIIF-like subunit complexes as integral parts of the 
polymerase (Fernandez-Tornero et al., 2013; Iben et al., 2011; Kuhn et al., 2007). TFIIF 
in pol II has been implicated in pause suppression, transcription start-site selection, and 
termination (Ghazy et al., 2004; Ishibashi et al., 2014; Kubicek et al., 2013; Schweikhard 
et al., 2014). Interestingly, the TFIIF-like sub-complex in pol III (C53/37) has also been 
implicated in the termination step of pol III along with the N-terminal domain of the 
Rpb9 homologous subunit C11 (Iben et al., 2011). It is also significant to point out that 
these polymerases, which differ greatly in their promoter organization, also require 
initiation factors such as TBP and TFIIB (homologous subunits Rrn3 and TFIIIB in pol I 
and III, respectively) in addition to their TFIIF-like subunits. Thus it seems though there 
is strong similarity between the three eukaryotic polymerases, each polymerase has 
evolved template-specific differences in structure and function in order to fulfill its 
34 
cellular role without necessarily “reinventing” the transcription wheel. Some of the 
significant differences and structural features of pol I, II, and III are detailed in Table 
1.1. 
Summary of introduction 
Transcriptional fidelity is vital to faithfully utilizing the coded information stored 
in DNA, and understanding how fidelity is maintained is essential to the greater 
understanding of this basic component of life. Experiments in both prokaryotic and 
eukaryotic systems have identified certain structural elements within RNAPs that govern 
aspects of transcriptional fidelity. One of those elements is the TL, which moves in and 
out of the active site helping to ensure selection of the correct substrate nucleotide and 
providing a means for maintaining an evolutionarily tuned speed of transcription. 
Appropriate TL mobility is thus critical to all aspects of transcription. 
In the chapters that follow, I provide evidence for a mechanism to explain how 
the small pol II subunit Rpb9 could affect the mobility of the TL. In addition, I present 
initial experiments designed to formulate and better understanding of the genetic 
interactions between RPB9 and genes that encode various co-transcriptional complexes. 
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S. cerevisiae RNA polymerase                           Pol I              Pol II              Pol III 
Core enzyme 
A190 Rpb1 C160 
A135 Rpb2 C128 
A40 Rpb3 A40 
A19 Rpb11 A19 
A12.2 Rpb9 C11 
Rpb5 Rpb5 Rpb5 
Rpb6 Rpb6 Rpb6 
Rpb8 Rpb8 Rpb8 
Rpb10 Rpb10 Rpb10 
Rpb12 Rpb12 Rpb12 
Rpb4/7 subcomplex 
A14 Rpb4 C17 
A43 Rpb7 C25 
TFIIF-like subcomplex 
A49 (Tfg1) C37 
A34.5 (Tfg2) C53 
Pol III-specific subcomplex 
- - C82 
- - C34 
- - C31 
Extrinsic factor required for transcript 
cleavage? 
No (A12.2) Yes (TFIIS) No (C11) 
Estimated in vivo transcription rate 
(nucleotides/second) a 
~50 ~30 - 
Estimated in vitro transcription rate 
(nucleotides/second) b 
~20  ~12  ~20  
Intrinsic cleavage activity required for 
termination? c 
No No Yes 
Presence of TL and BH in active center? d Yes Yes Yes 
Table 1.1: Notable differences of yeast nuclear polymerases 
( a ) (Mason and Struhl, 2005; Turowski and Tollervey, 2015) ( b ) (Kaplan, 2008; 
Matsuzaki et al., 1994; Viktorovskaya et al., 2013) ( c and d ) (Cramer et al., 2008) 
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CHAPTER II 
MATERIALS AND METHODS 
 
Yeast strains, media, cloning, and preparations of whole cell extracts 
 
Yeast strains and media 
 
All yeast strains utilized were derived from three different parental strains 
obtained from different sources. One parental strain (generously provided by Mikhail 
Kashlev) was derived from the protease-deficient BJ5464 strain (Kireeva et al., 2003) 
with the RPB3 ORF modified to contain a 6X-His tag and a BirA binding sequence. This 
strain was the source of purified pol II and pol II∆9, which were isolated as described 
(Knippa and Peterson), and it was also utilized in in vitro experiments in which pol II 
was immobilized from whole cell extracts using Ni2+-NTA beads. A second parental 
strain (generously provided by Craig Kaplan) was derived from a GAL2+ S288C strain 
containing a TAP-tag in the ORF of RPB3, rpb1Δ::cloNATMx supplemented with a CEN 
URA3 RPB1 plasmid, and the lys2-126δ allele (Simchen et al., 1984). This background 
also harbored the gal10Δ56 allele which contains a mutation in the GAL10 
polyadenylation signal used to report on the GalS phenotype (Greger and Proudfoot, 
1998). The third strain was BY4741, also derived from S288C, which is the strain in 
which the yeast knockout collection was constructed.  
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 Gene deletions were generated by PCR-generated gene disruption as described 
(Baudin et al., 1993; Brachmann et al., 1998) or obtained as haploids from the yeast 
deletion library (Dharmacon). Gene deletions that are synthetic lethal with rpb9Δ were 
generated by genetic cross of rpb9Δ::HIS3 or rpb9::TRP1 (supplemented with a single-
copy URA3-marked plasmid containing RPB9) with a strain containing the KanMX4 
knockout of HTZ1, GCN5, SPT7, or SCW5, and screening random spores for the desired 
genotype. 
 
Media 
 
Growth and general manipulation of yeast strains were done using standard 
protocols (Spencer, 1989). All media was prepared using standard protocols (Spencer, 
1989). Media used for phenotyping was supplemented with drugs where indicated. 
Media used for GalS phenotyping (Kaplan, 2008) contained either 2% Raffinose, or 2% 
Raffinose/ 1% Galactose supplemented with antimycin A (1μg/mL).  
 
Cloning 
 
RPB9 mutations were constructed by site-directed mutagenesis (Baudin et al., 
1993; Brachmann et al., 1998), as were RPB1 mutations rpb1-R711A, -E712A, and -
(707-709A). RPB1 mutations at residue S713, or any other TL residue were the generous 
gift of Craig Kaplan. Shuffles of various rpb1 mutations were performed as in (Kaplan, 
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2008). Briefly, rpb1 mutations were sub-cloned from a plasmid containing only a 
portion of the RPB1 ORF, ligated into the full-length RPB1 ORF on a plasmid marked 
with LEU2, and confirmed by sequencing. Plasmids containing the rpb1 mutation of 
interest was then transformed into the rpb1Δ background via plasmid shuffle.   
 
Whole cell extracts 
 
All WCEs were prepared as described previously by (Kireeva et al., 2003; 
Knippa and Peterson, 2013).  
 
Rpb9 purification of recombinant Rpb9 
 
 Rpb9 and the Rpb9 variant were purified essentially as in (Ruan, 2011) with 
several minor changes. DNA encoding N-terminal Flag-tagged Rpb9 or Rpb9-(95-97)A 
was amplified by PCR, digested with NdeI and XhoI, and ligated into the pET28a 
expression vector (Novagen), which added a 6X-His tag onto the N-terminus of each 
ORF.  Plasmid construction was verified by sequencing. BL21(DE3) E. coli cells were 
transformed with plasmids containing Rpb9, Rpb9-(95-97)A, or the empty vector. Cells 
were then grown to A600 =0.6 at 37°C. Cells were then shifted to 18°C and induced 
overnight by the addition of 40 μM IPTG. Cells were lysed by sonication in PBS 
supplement with a protease inhibitor cocktail 1:1000 (Calbiochem) and 10 μM ZnCl2. 
The lysate was subsequently clarified by several rounds of centrifugation at 4°C. Crude 
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lysate was applied to a 1 mL Histrap column (GE Healthcare) that had previously been 
washed with 100 mM NiSO4 solution and equilibrated in purification buffer as described 
(Ruan, 2011). The column was washed with 10 column volumes of equilibrating buffer, 
buffer containing 2M NaCl and 10mM imidazole, followed by buffer containing 100mM 
NaCl and 40 mM imidazole, and finally by buffer containing 100mM NaCl and 100 mM 
imidazole. Protein was then eluted from the column by addition of purification buffer 
containing 300mM imidazole. Fractions containing eluted proteins were concentrated 
with a 30 kDa cut-off spin concentration, followed by further concentration with a 10 
kDa cut-off spin concentrator. SDS-polyacrylamide gel electrophoresis of the 
concentrate (~0.1 mg/mL) showed only a single band, which was of the size expected for 
recombinant Rpb9 and which contained the flag epitope as revealed by Western blot 
with a flag antibody. 
 
In vitro transcription assays 
 
RNA/DNA hybrid formation and RNA labeling 
 
Template, non-template, and RNA oligomers were either purchased from Integrated 
DNA Technologies or graciously supplied by Craig Kaplan (long template assays). 
RNAs were labeled at the 5’-end in transcription buffer (TB) 40 [20 mM Tris-HCl (pH 
7.9), 40 mM KCl, 5 mM MgCl2, 2mM 2-mercaptoethanol] using T4 polynucleotide 
kinase and 16.7 pmol of [γ-32P] ATP (Perkin-Elmer). The labeled RNA was then 
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annealed to the template DNA (16.7 pmol) as described (Kireeva et al., 2003). Substrate 
NTPs used for misincorporation and correct nucleotide extension assays were obtained 
from GE Healthcare. 
 
Assembly of elongation complexes 
 
Elongation complexes were assembled identical to those described by (Knippa 
and Peterson, 2013) For assays using purified polymerase, pol II or pol II lacking Rpb9 
(250 ng) was added to 25 μL of Ni2+-NTA beads, which had been equilibrated in 
transcription buffer. For assays using WCEs, 25-50 μL was added to the same amount of 
Ni2+-NTA or human IgG-agarose beads for strains carrying the Rpb3 TAP-tag. Purified 
pol II or pol II from WCEs was then allowed to bind the beads for 30 minutes at room 
temperature in an orbital shaker. After the initial incubation, beads were washed with 1 
mL of transcription buffer identical to TB(40) except with 1 mM KCl [TB(1000)] for 10 
min, followed by three 1 mL washes with TB(40). The pre-annealed RNA/DNA hybrid 
(1 pmol) was then added to the beads in a total volume of 100-150 μL and incubated for 
10 min, followed by the addition of the non-template strand which was allowed to 
incubate for an addition 10 min. Elongation complexes (ECs) were then washed with 1 
mL of TB(1000) for 10 min followed by 3 washes of TB(40). Final volume of washed 
elongation complexes was 100- 200 μL. Substrate NTPs were added, and aliquots 
(10µL) of the reaction mixture were removed at various time intervals (10 μL) and 
added to 10 μL of 2X loading buffer, which stopped the treaction. Resulting extension 
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products were resolved in 13.5% (long templates) or 20% polyacrylamide gels as 
described in (Kaplan, 2008; Knippa and Peterson, 2013). For assays with recombinant 
Rpb9 or Rpb9-(95-97)A, an additional wash step with 1 mL of Sarkosyl (0.035%) was 
incorporated between the initial TB(40) and TB(1000) washes during EC assembly. The 
amount of purified Rpb9 or Rpb9- (95-97)A added to the complexes is an amount to 
make the concentration of Rpb9 in solution (500 nM), ~20 times higher than that of the 
published binding constant of wild-type Rpb9 (Hemming and Edwards, 2000). For 
assays using α-amanitin (Calbiochem), assembled complexes were incubated with α-
amanitin for 15 min before addition of NTPs. Quantification of extension products for 
all assays was done using Bio-Rad PharosFX Plus, and curve plots were prepared using 
Kaleidagraph graphing utility. 
 
Western blotting 
 
WCEs derived from strains with an empty vector (pRS413), or the same vector 
containing DNA encoding either Rpb9 or the Rpb9- (95-97)A, were added to 10 μL of 
Ni2+-NTA beads for 30 minutes and washed as described for preparation of ECs. After 
the washes, most of the final wash buffer was removed to reduce the volume to 
approximately 20-30 μL, and 20 μL of 2X Laemmli buffer (120 mM Tris-HCl at pH 6.8, 
20% glycerol, 4% SDS, 0.005% bromophenol blue, and 5% 2-mercaptoethanol) was 
added. Samples were boiled for 2 minutes and loaded onto a 4-20% SDS polyacrylamide 
gel along with molecular weight size standards. The resolved proteins were transferred 
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to a PVDF membrane overnight at room temperature. The membrane was then blocked 
in a 3% non-fat dry milk/TBS solution for 1 hour followed by an overnight incubation at 
4 oC with anti-Flag antibody (Sigma) (diluted 1:1,000 in  3% non-fat dry milk/TBS). 
After the incubation, the blot was rinsed several times in H2O, followed by 5 washes 
with TBS. Anti-mouse IgG 1:30,000 was then added to the blot and incubated for 30 
minutes at room temperature, followed by 5 washes with TBS. The blot was visualized 
with incubation of Supersignal West Femto (Thermo) for 5 minutes, with the signal 
detected by a chemiluminescent imager (Bio-Rad ChemiDoc XRS). In order to compare 
the ratios of Rpb9 and Rpb9- (95-97)A to the Rpb1 subunit to address possible defects in 
association, blots were washed and blocked as described previously, probed with anti-
RNA pol II 8WG16 1:500 at 4 oC overnight, and imaged as above.  
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CHAPTER III 
A STRUCTURAL MODEL FOR TRIGGER LOOP-DEPENDENT 
RPB9 FUNCTION IN TRANSCRIPTION 
 
Summary 
      
          The small RNA polymerase II (pol II) subunit Rpb9, though nonessential, has 
been shown to contribute to polymerase activity in several ways. The loss of Rpb9 (pol 
IIΔ9) results in a faster polymerase, as well as one with a decreased ability to proofread 
mistakes in the RNA chain, rendering it more error-prone. In addition, though far from 
the active center, the loss of Rpb9 increases NTP sequestration at the active site prior to 
new phosphodiester bond formation. This suggested that Rpb9 may act by delaying the 
closure of the Trigger Loop (TL), a mobile element within the interior of the polymerase 
important for correct nucleotide selection and catalysis. To test whether Rpb9 functions 
by affecting TL movement, we took advantage of the RNA polymerase inhibitor α-
amanitin, which binds tightly to the polymerase, preventing closure of the TL. If there 
are any effects on TL movement due to the loss of Rpb9, the expectation was that in the 
presence of α-amanitin, these effects should disappear. Using this approach, we showed 
that the rates of misincorporation for a non-complementary NTP, normally 2- to 3-fold 
faster for pol IIΔ9 compared to pol II, become identical in the presence of the inhibitor, 
suggesting that the faster rate of misincorporation for pol IIΔ9 is dependent on the TL. 
However, a faster rate for correct NTP incorporation was still observed in pol IIΔ9, even 
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in the presence of α-amanitin, also suggesting a TL-independent role for Rpb9. Insights 
into the structural mechanism of this Rpb9-TL interaction were gained through utilizing 
a previously described sit1 mutation, rpb1-G730D, which has been shown to have a 
negative in vivo interaction with RPB9. In particular, we have identified a mutation, 
rpb9-(95-97)A, that relieves this negative interaction and mimics behavior of rpb9Δ in 
vivo, and in vitro. Upon close examination of the structure of pol II and the position of 
Rpb9 residues 95-97, we identified potential interaction interfaces between Rpb9 and a 
loop of Rpb1 positioned between the Rpb9 C-terminal domain and the TL, termed the 
Anchor Loop (AL). Using site-directed mutagenesis, we targeted residues that affected 
Rpb9-AL and AL-TL interactions. Mutations that mimicked the in vivo and in vitro traits 
of rpb9Δ were found at each interface which was unchanged when these mutations were 
combined with rpb9Δ. Moreover, in a NTP misincorporation assay, the effects of all 
these mutations disappeared in the presence of α-amanitin, indicating that they depend 
on TL movement. Taken together, these data demonstrate a molecular pathway for TL-
dependent effects of Rpb9 on transcription.  
 
Introduction  
  
Rpb9 is a small (122 amino acids in S. cerevisiae) subunit of RNA polymerase II 
(pol II) that is highly conserved among eukaryotes. It is composed of two zinc ribbon 
domains characterized by the zinc-chelating motif (CX2CXnCX2C). Although Rpb9 is 
not essential for growth in yeast, rpb9 null mutants have a number of phenotypes, 
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including slow growth (Li et al., 2006), hypersensitivity to several drugs (Gibney et al., 
2008; Koyama, 2007; Li et al., 2006), upstream shifts in transcription start site (Hull et 
al., 1995; Sun et al., 1996), defects in transcription-coupled repair that result in enhanced 
sensitivity to UV light (Chen et al., 2007), and decreased transcriptional fidelity in vivo 
(Koyama, 2007; Nesser et al., 2006) and in vitro (Knippa and Peterson, 2013; Walmacq 
et al., 2009). 
 The fidelity defect of pol II that is lacking Rpb9 (pol II∆9) has been examined in 
several studies. Decreased selectivity for correct (complementary to the DNA template) 
versus incorrect NTP substrates has been observed (Walmacq et al., 2009). However, 
our published experiments did not provide evidence for a selectivity defect, and, in our 
hands, the decreased fidelity of pol II∆9 appears to be the result of inefficient 
proofreading caused by an increased rate of RNA extension from a mismatched 3'-end 
combined with a decreased efficiency of TFIIS-mediated mismatch removal (Knippa 
and Peterson, 2013). A role for Rpb9 in fidelity is consistent with reported roles for the 
corresponding subunits in RNA polymerases I and III (A12.2 and C11, respectively) 
(Chedin et al., 1998; Kuhn et al., 2007), as well as the related archaeal protein TFS 
(Hausner et al., 2000; Lange and Hausner, 2004). 
Rpb9 is located on the leading edge of the elongating polymerase at a position 
that is not in immediate proximity to the active site (Kettenberger, 2003), and the 
absence of Rpb9 has little or no effect on the binding affinity of TFIIS with the 
polymerase (Awrey, 1997). This leaves open the question of how Rpb9 exerts its effects 
on elongation and cleavage. Using rapid quench-flow kinetic techniques, Walmacq, et al. 
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(Walmacq et al., 2009) demonstrated that Rpb9 promotes the sequestration of NTP 
substrates in the active site prior to formation of a new phosphodiester bond. This 
behavior was similar to that observed with pol II containing Rpb1-E1103G (hereafter 
abbreviated pol II-(Rpb1E1103G), a mutation within the trigger loop (TL), a mobile 
structural element that closes on the pol II active site and interacts with the substrate 
NTP reviewed in (Kaplan, 2010). Based on the similar behavior of pol II∆9 and pol II-
(Rpb1E1103G), it was proposed that the C-terminal domain of Rpb9 interacts directly 
with the open pol II TL (Walmacq et al., 2009). However, in this same study, direct 
mutational analysis of an amino acid (Rpb9-K93) thought to interact with the TL showed 
no fidelity defect.  
As discussed in Chapter I, the TL has been implicated in several functions during 
the transcription cycle, including, start-site selection, transcriptional fidelity, and 
determination of the overall catalytic rate (Brueckner and Cramer, 2008; Jin and Kaplan, 
2015; Kaplan et al., 2012; Kaplan, 2008; Mejia et al., 2015; Sydow, 2009a; Sydow, 
2009b; Wang et al., 2013). Effects on the transition of the TL from the open to closed 
state have been suggested to impact all of these processes (Wang et al., 2015; Wang et 
al., 2013). Genetic, single-molecule, and computational analyses have at least partially 
defined structural features of the TL that are important for its transition into and out of 
the active site. In addition to E1103, several other residues in the C-terminal hinge area 
of the TL, such as G1097, P1099, and L1101, also exhibit behavior consistent with an 
effect on TL mobility (Kaplan et al., 2012; Kireeva et al., 2012) . Intriguingly, these 
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mutations also demonstrate in vivo and in vitro phenotypes similar to rpb9∆, and as we 
have found in many cases, are similarly synthetically lethal (Appendix Fig. 1).   
Based on the similarities between rpb9∆ and mutations in the TL that have been 
predicted to affect TL mobility, it is very likely that Rpb9 does affect TL movement. 
However, to date, no biochemical mechanism for such an effect has been defined. In this 
study we provide additional genetic and biochemical evidence that Rpb9 affects pol II 
activity through the TL, describe a plausible biochemical model for how this could 
occur, and confirm predictions suggested by this model related to the phenotypes of 
certain alleles of RPB9 and RBP1. 
 
Results 
 
Effect of Rpb9 on pol II activity in the presence of α-amanitin 
 
 While previous work had shown that the absence of Rpb9 promotes NTP 
sequestration in the pol II active site, the proposed mechanism, in which sequestration is 
increased through altered mobility of the TL, was without direct experimental support 
(Walmacq et al., 2009). We decided to test the general idea that Rpb9 affects TL 
mobility using an experimental approach that exploits the mushroom toxin α-amanitin, 
which has been shown to inhibit pol II by locking the TL in a position where it cannot 
participate directly in active site chemistry (Kaplan, 2008). We reasoned that if Rpb9 
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affects TL mobility, then, by immobilizing the TL with α-amanitin, the effects of Rpb9 
on pol II activity would be markedly affected. 
 We have previously reported that the absence of Rpb9 increases the rate of pol 
II-catalyzed RNA synthesis in a single-nucleotide misincorporation assay (Knippa and 
Peterson, 2013). To assess the effect of α-amanitin on misincorporation, purified pol II 
or pol II∆9 was immobilized on Ni2+-NTA beads via a 6x-His tag on Rpb3, and 
elongation complexes (ECs) were assembled with DNA and RNA oligonucleotides in 
which the 10 nt RNA was completely complementary to the template DNA and was 5'-
end labeled with 32P (Fig. 3.1A).  Instead of the template-specified CTP, ATP (1 mM) 
was added, and the time course of A-for-C misincorporation was followed in the 
presence or absence of α-amanitin (Fig. 3.1, B and C). The fraction extended to 11 nt 
was plotted against time, and the data were fit to a single exponential equation. We 
confirmed that the extension to 11 nt was the result of misincorporation, and not the 
result of contaminating CTP, as the 11 nt product was not rapidly extended by addition 
of CTP, GTP, and UTP (data not shown), consistent with a mismatched 3'-end. In the 
absence of α-amanitin, the misincorporation rate for pol II was about half that observed 
for pol II∆9 (Fig. 3.1D), consistent with our previously reported observations (Knippa 
and Peterson, 2013), but in the presence of α-amanitin (160 µg/mL), the rates for pol II 
and pol II∆9 were almost identical (Fig. 3.1E). This concentration of α-amanitin was 
saturating, as concentrations as high as 640 µg/mL had no increased effect on the rate. 
Overall, the misincorporation reaction was not very sensitive to α-amanitin (2.3-fold and 
4.8-fold for pol II and pol II∆9, respectively), consistent with previous observations  
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    (A) The EC complex with template/non-template DNA combinations used for 
misincorporation assay as well as the pre-annealed 5’-
32
P labeled RNA (red). 
Complexes were formed as described in material and methods with purified pol II. 
The gray circle indicates the approximate position of pol II and the black box 
indicates the i+1 nucleotide positon (CTP per the template). (B and C)  ATP 1mM was 
added to ECs with pol II or pol II∆9 alone or ECs pre-incubated with α-amanitin, and 
the extension of the RNA to 11 nucleotides (nt) or greater was monitored over time 
via a 20% polyacrylamide gel. (D and E)The fraction extended to 11 nts in B and C 
was plotted and fit to a single exponential function to obtain an observed rate for 
misincorporation, indicated by each curve. The fraction elongated was divided by the 
extent of the reaction as determined by curve fit. Experiments here and in Fig. 3.2 
were  performed by Knippa, K.C.  
Figure 3.1: Pol II∆9 rate increase for an ATP misincorporation is dependent on α-
amanitin 
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(Kaplan, 2008), but immobilization of the TL by α-amanitin completely eliminated the 
effect of Rpb9 on the rate. This observation is consistent with the idea that the effect of 
Rpb9 on the rate of misincorporation is mediated, at least in part, by affecting the TL. 
 To assess the effect of α-amanitin on the much more rapid rate of elongation with 
template-matched NTPs, we took advantage of a method in which the rate of elongation 
was estimated as the average rate at which the polymerase completes transcription across 
a relatively long DNA template (Kaplan, 2008). ECs were assembled as shown in Fig. 
3.2A, all four NTPs were added simultaneously, and transcription was monitored over 
time. After gel electrophoresis of the RNA products, the halftime for the appearance of 
products greater than 60 nt in length was estimated, and the average rate of elongation 
was calculated by dividing the actual number of nt synthesized (51 nt) by the halftime. 
At NTP concentrations of 1mM each, which was near saturation for both pol II and pol 
II∆9, the average rate of elongation was about 2.5 times faster in the absence of Rpb9 
(11.5 nt•s-1 versus 4.5 nt•s-1), and remained about twice as fast in the presence of 
saturating α-amanitin. Overall, however, this assay was much more sensitive to α-
amanitin inhibition than the misincorporation assay (about 50-fold for both pol II and pol 
II∆9) (Fig. 3.2B). This observation does not provide support for the idea that Rbp9 
affects the TL. However, this pattern of differential α-amanitin sensitivity for template-
matched and mismatched NTP substrates has also been observed with pol II-
(Rpb1E1103G), a polymerase with a substitution at one of the TL hinge regions that, 
like the absence of Rpb9, results in a faster elongation rate (Kaplan, 2008), presumably 
by affecting TL mobility (Walmacq et al., 2009). This somewhat unexpected behavior of  
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 (A) The EC complex with template/non-template DNA combinations used to 
determine the average correct nucleotide extension rate as in Fig. 3.1 except that a 
much longer template/non-template DNA (80 nt) was used in order to extend the 
measurable time period for pol II extension. (B and C)  A-, C,-, G, and UTP 1mM 
were simultaneously added to ECs with pol II or pol II∆9 alone or ECs pre-incubated 
with α-amanitin. The fraction of RNA extended to 61 nt (or 34 nts or greater for α-
amanitin experiments), forming a product of 51nt, was plotted and fit with a non-
linear equation to determine the half-time (D and E). The extension rate in nt/s was 
determined by dividing the length of the extension product n- nucleotides long by the 
half-time.   
Figure 3.2: Pol II∆9 average correct nucleotide extension rate is not dependent 
on α-amanitin 
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pol II-(Rpb1E1103G) (and perhaps that of pol II∆9) may be due to effects that are 
independent of the TL, but this seems unlikely for E1103G, as the amino acid 
substitution is actually within a hinge region of the TL. Alternatively, it is possible that 
the rapid rate of elongation with template-matched NTPs could compete with the "on" 
rate of α-amanitin binding such that the small amount of free pol II in equilibrium with 
α-amanitin-bound pol II could, during its brief period of freedom from the inhibitor, 
sometimes elongate, and this would be more likely to occur in a variant with a faster 
elongation rate. 
Overall, the α-amanitin experiments were not conclusive with regard to a 
potential effect of Rpb9 on the TL. The effect of α-amanitin in the misincorporation 
assay was consistent with the idea that the effect of Rpb9 on pol II activity is dependent 
on TL mobility, but its effect on elongation with template-matched NTPs was not. 
However, pol II-(Rpb1E1103G), a fast polymerase with an alteration in TL mobility, and 
pol II∆9 responded almost identically to α-amanitin. 
Rpb9 mutations that suppress sit1-7 (rpb1-G730D) 
Concurrent with the α-amanitin experiments described above, we took a more 
general approach to identify mutations that affect Rpb9 function. The sit1-7 mutation 
(Suppressor of Initiation of Transcription), an allele of RPB1 (rpb1-G730D) was 
originally isolated based on its ability to support low level transcription from the HIS4 
gene in the absence of normally required activating factors, and later implicated in 
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transcriptional elongation based on its location in a region of Rpb1 that was associated 
with α-amanitin resistance (Archambault et al., 1998).  Subsequently, this mutation was 
re-isolated by Koyama, et al. (Koyama et al., 2010) as a suppressor of the menadione 
hypersensitivity of rpb9∆ strains. A severe growth defect is conferred by rpb1-G730D in 
the presence of RPB9, but near wild-type growth can be restored by   deletion of Rpb9 
residues 48-122, 65-70, or 89-95 (Koyama et al., 2010). Previous experiments had 
shown that these deletions do not prevent binding of Rpb9 to pol II (Chen et al., 2007; 
Hemming and Edwards, 2000), and thus it is likely that some kind of negative 
interaction between RPB9 and rpb1-G730D is mediated through the C-terminal half of 
the 122-residue Rpb9. Pol II carrying the Rpb1-G730D alteration was subsequently 
shown to be very slow, with an elongation rate only about 10% that of wild-type pol II 
(Walmacq et al., 2012). We observed that the absence of Rpb9 restores a near wild-type 
in vitro elongation rate to pol II (Rpb1-G730D) (Appendix Fig. 2A-D), suggesting that 
specific rpb9 alleles that relieve the negative genetic interaction with rpb1-G730D, such 
as those that delete Rpb9 residues 48-122, 65-70, or 89-95, might also have this effect. 
Therefore, we decided to screen additional rpb9 alleles for their ability to relieve the 
negative interaction between RPB9 and rpb1-G730D. 
 Our initial results are consistent with the results of Koyama, et al. (Koyama et 
al., 2010) (Fig. 3.3A). The severe growth defect in rpb1-G730D RPB9 strains was 
partially relieved when RPB9 was deleted, and the rpb1-G730D rpb9∆ strain retained 
only the growth defect caused by rpb9∆. Providing RPB9 on a single-copy plasmid 
restored the negative interaction with rpb1-G730D, as did an allele that changed Rpb9  
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 (A) 10-fold serial dilutions of various plasmid-borne Rpb9 mutants in the context of 
the rpb1- G730D mutation were spotted on the indicated media from saturated liquid 
cultures, and monitored for growth for several days. The C-terminal truncation 
mutant rpb9- (1-59) and the deletion mutant rpb9- (88-97)Δ relieve the negative 
interaction of RPB9 and rpb1- G730D. (B) Mutations in the regions of Rpb9 thought 
to be important for the rpb1- G730D interaction were introduced via site-directed 
mutagenesis, combined in the context of the rpb1 mutations, and spotted on synthetic 
media, or media containing MPA (5 μg/mL). Rpb9- (95-97)A relieves the negative 
interaction with rpb1- G730D, while restoring wild-type growth.  
 
Figure 3.3: The rpb9- (95-97)A mutation relieves the negative interaction of the 
Rpb9 C-terminal domain with the sit1 mutant rpb1- G730D 
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amino acids 91-94 to alanine (rpb9-(91-94)A). However, deletion of amino acids 88-97 
(rpb9-(88-97)∆) or an allele encoding only the N-terminal 59 amino acids of Rpb9 
(rpb9-(1-59)) did not restore this negative interaction. Rpb9 encoded by all of the tested 
alleles appeared to be expressed and capable of associating with pol II, as all of them 
restored near wild-type growth to a RPB1 rpb9∆ strain, and in the rpb1-G730D rpb9∆ 
background, both rpb9-(1-59) and rpb9-(88-97)∆ grew significantly better than when the 
vector alone was present. These results strongly suggest that Rpb9 residues 88-90 and/or 
95-97 play a major role in the negative interaction between RPB9 and rpb1-G730D. 
 Additional rpb9 alleles were constructed to further dissect this region of the 
protein (Fig. 3.3B, left panel). rpb9-Q87A, rpb9-S96A, rpb9-(88-90)A, and rpb9-(95-
97)A all restore wild-type growth to a rpb9∆ strain, but only rpb9-(95-97)A also 
completely avoids the negative interaction with rpb1-G730D (Fig. 3.3B, left panel). 
rpb9-(95-97)A is also unique among these alleles in that it confers moderate 
hypersensitivity to mycophenolic acid (MPA) in a RPB1 background (Fig. 3.3B, right 
panel). MPA is a potent inhibitor of IMP dehydrogenase, an enzyme important in purine 
biosynthesis. It has been widely assumed that MPA hypersensitivity in yeast is indicative 
of a defect in transcription elongation. However, a number of studies strongly indicate 
that the hypersensitivity is almost always a much more specific defect that results from 
the failure of low concentrations of GTP to cause induction of the yeast IMD2 gene, 
which encodes a relatively MPA-resistant form of IMP dehydrogenase (Hyle et al., 
2003; Kaplan et al., 2012). Induction is caused by a downstream shift in transcription 
initiation site that is required to generate the long, stable transcript that includes the 
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ORF. Thus, strains with mutations that prevent the efficient shift from the upstream start 
site (which begins with GTP) to the downstream site (which begins with ATP) when 
GTP concentrations are low become MPA hypersensitive. Recent evidence suggests that 
one (but certainly not the only) determinant of transcription initiation site selection in 
yeast is the elongation rate of pol II, the faster the elongation rate, the more 
hypersensitive to MPA, presumably because the fast polymerases constitutively initiate 
at the upstream start site even in the presence of low GTP concentrations (Kaplan et al., 
2012). These results indicate that Rpb9-(95-97)A is missing a function that is required 
for both the negative interaction with Rpb1-G730D and for the efficient induction of 
IMD2 transcription. However, hypersensitivity to MPA is significantly higher in a rpb9∆ 
strain compared to rpb9-(95-97)A, suggesting that there may be more than one function 
in Rpb9 that contributes to MPA resistance, as will be discussed in Chapter IV. This is 
consistent with observations that the N-terminal domain of Rpb9 alone (amino acids 1-
57 (Van Mullem et al., 2002) or 1-59 (our unpublished observation) is sufficient to 
partially relieve the MPA hypersensitivity of rpb9∆ strains. The ability of Rpb9-(95-
97)A to mimic the absence of Rpb9 in some contexts appears not to be the result of an 
inability of Rpb9-(95-97)A to bind the polymerase, as some contexts (e.g. in a rpb1-
G730D strain) create phenotypes unique to rpb9-(95-97)A. This is consistent with 
published work in which amino acid substitutions near this region of Rpb9 do not affect 
pol II binding (Hemming and Edwards, 2000), but we address this issue more directly 
below. 
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  (A) ATP 1mM was added to ECs immobilized from WCEs with pol II (WT), rpb9- 
(95-97)A pol II, and  pol II∆9 and the extension of the RNA to 11 nucleotides (nt) or 
greater was monitored over time via a  20% polyacrylamide gel. (B)The fraction 
extended to 11 nts in A was plotted and fit to a single exponential function to obtain 
an observed rate for misincorporation, indicated by each representative assay. (C) as 
in A, except ECs pre-incubated with α-amanitin for 15 minutes. (D) Same as B.  
Figure 3.4: ECs derived from a strain with the Rpb9- (95-97)A variant mimic in 
vitro behavior of pol II∆9 for an ATP misincorporation 
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Rpb9- (95-97)A mimics the behavior of pol II∆9 in vitro  
 
 The rpb9-(95-97)A and rpb9∆ strains share a number of in vivo phenotypes, (Fig. 
3.3), and we sought to determine whether in vitro properties of pol II are affected when 
Rpb9 is replaced by Rpb9- (95-97)A. In these assays we immobilized pol II from whole 
cell extracts (WCE) from a rpb9∆ strain carrying a plasmid-born rpb9-(95-97)A by 
exploiting a TAP tag on Rpb3 (Kaplan, 2008). In an A-for-C misincorporation 
experiment performed at a near saturating concentration of ATP (1 mM), the Rpb9- (95-
97)A substitutions resulted in a misincorporation rate almost twice that of pol II 
immobilized from wild-type WCE and essentially identical to the rate of pol II from 
WCE of rpb9∆ cells (Fig. 3.4, A and B). In the presence of α-amanitin, the rates of 
misincorporation for polymerase immobilized from all three strains were essentially 
identical, consistent with a possible effect of the (95-97)A substitutions on TL function.  
 We directly addressed the possibility that the alterations in Rpb9 amino acids 95-
97 might affect the binding of Rpb9 to pol II in two ways. In a pull-down assay, we 
exploited a rpb9∆ strain with a 6x-His tag on Rpb3 that contained a plasmid-borne copy 
of either RPB9 or rpb9-(95-97)A, each of which was flag-epitope tagged at its N-
terminus. Pol II was immobilized from WCEs derived from these strains using Ni2+-
NTA beads, and the beads were washed just as they would be for an in vitro 
transcription assay. Bead-bound proteins were dissolved in SDS, fractionated by SDS-
PAGE, and Rpb9 was identified by Western blot analysis with an anti-flag antibody  
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WCEs containing N-terminally Flag-tagged Rpb9 or Rpb9- (95-97)A expressed from 
a single-copy plasmid were analyzed with a Western blot under the same conditions 
used for in vitro transcription assays. This was done in order to determined their 
association with pol II based on signal from a probe detecting the Flag-epitope (upper 
box) and the CTD of pol II (8WG16) (lower box) as described in the materials and 
methods chapter. The ratio of the signal of α- Flag to α- Pol II CTD under each lane is 
normalized to the RPB9 strain (n=1). 
  
Figure 3.5: Association of Rpb9- (95-97)A with pol II 
 
Figure 3.5: Association of Rpb9- (95-97)A with pol II 
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(Fig. 3.5). A protein band of approximately 14 kDa, consistent with the size of Rpb9, 
was detected in lanes derived from extracts from cells with the RPB9 or rpb9-(95-97)A 
plasmid, but not the control extract made from cells carrying only the empty vector. The 
membrane was also probed with an antibody against the Rpb1 C-terminal domain (Fig. 
3.5, upper box). Quantitation yielded a ratio of Rpb1 to Rpb9 for rpb9- (95-97)A was 
very similar to that of wild-type Rpb9, indicating there is no major defect for binding in 
the Rpb9 variant. This is not surprising , as the area critical for Rpb9 binding resides in 
residues nearer to the linker of Rpb9 (Hemming and Edwards, 2000). These results were 
not affected by the presence of the eight amino acid flag-epitope tag, as all of the RPB9 
alleles shown in Fig. 3.3 contain it.   
 Our second approach was based on in vitro experiments with pol II, where the 
slow rpb1-G730D mutation could suppress the fast misincorporation rate of pol II∆9, but 
not the fast rate of pol II-(Rpb9-(95-97)A). We took advantage of published methods for 
bacterial expression and purification of Rpb9 that were developed for x-ray 
crystallographic studies of Rpb9 and its pol II counterpart C11 (Ruan, 2011). Our 
preparations contained highly purified Rbp9 (Appendix Fig. 5). When we attempted to 
reconstitute wild-type pol II behavior with purified Rpb9 and pol II∆9 that had been 
immobilized from WCE with a 6x His-tag on Rpb3, we found that the best protocol was 
to assemble ECs with pol II∆9 and then add the purified Rpb9. In addition, we found 
that in order for the added Rpb9 to affect the activity of pol II∆9 ECs, the presence of a 
low concentration of Sarkosyl (0.035%) was required. However, the Sarkosyl addition 
had no effect on the activity of ECs containing pol II or pol II∆9 in the absence of added 
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recombinant Rpb9 (Appendix Fig. 6). The activity of ECs reconstituted in this way 
exactly mimicked that of the ECs prepared directly from cell extracts derived from RPB1 
RPB9, RPB1 rpb9(95-97)A, rpb1-G730D RPB9,  and rpb1-G730Drpb9-(95-97)A 
strains, consistent with the idea that Rpb9-(95-97)A efficiently associates with pol II. 
 
A model for interaction between Rpb9 and the TL 
 
 Examination of the location of Rpb9 in numerous pol II crystal structures 
revealed that Rpb9 and the TL are never in sufficiently close proximity to allow for a 
direct interaction. However, the positions of Rpb9 amino acids 95-97 are in position to 
interact with the ends of Rpb1 α-helices 20 and 21, which form part of the "jaw" domain 
of pol II, as well as the small loop that connects them. Furthermore, in a crystal structure 
containing TFIIS in which the TL is captured in the most open conformation that has 
been observed (PDB 1Y1V) (Kettenberger et al., 2004), the TL is also positioned to 
interact with α-helix 21, which may stabilize the open state. Potential interacting 
residues are shown in Fig. 3.6. The model that emerges from this analysis is that Rpb9 
may anchor the ends of α-helices 20 and 21, as well as the loop between them, which we 
have termed the anchor loop (AL), so that the open TL position is stabilized. This 
provides time for binding of NTP substrate or proofreading of errors without TL 
interference. This is similar to a model proposed by Walmacq et al. (Walmacq et al., 
2009), but it does not involve direct interaction between Rpb9 and the TL, which 
Walmacq, et al. were not able to demonstrate. Instead, our model requires two  
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The crystal structure on the left (PDB: 1Y1V) indicates the relative positions of Rpb9 
C-terminal domain residues 95-97 and 112 (orange), the open TL conformation, and 
their proximity to the Anchor Loop (AL). The AL is located on α-21 distal to the 
rpb1-G730D mutation (red), and interacts with open conformation of the TL.  Rpb9 
may serve to optimize to the conformation of the AL necessary to stabilize the open 
TL, instead of a direct interaction between Rpb9 and the TL as proposed by Walmaq 
et al. 2009. Purple lines indicate hydrophobic interactions, while blue lines indicate 
hydrogen bonds. See text for further details.  
 
Figure 3.6: A new interaction model for Rpb9 and the TL 
 
Figure 4: Selected phenotypes of mutations located across 
the Rpb9-AL-TL interfacesFigure 5: A new interaction 
model for Rpb9 and the TL 
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interaction interfaces, one between Rpb9 and the AL, and a second between the AL and 
the TL. Interestingly, Rpb1-G730 is also in α-helix 21, and our model provides a 
plausible explanation for the negative genetic interaction between RPB9 and rpb1-
G730D. Substitution of glycine with the larger and negatively charged aspartate might 
disrupt the orientation of α-helix 21 and thereby affect the proposed interactions of the 
AL with Rpb9 and the open TL at the other end of the helix.  
 If the intramolecular interactions are as predicted, mutations that alter them 
should result in in vivo phenotypes that mimic at least some of the phenotypes of rpb9∆ 
strains. Some published observations are consistent with this idea.  For example, rpb1-
S713P, in which the proline would disrupt the N-terminus of α-helix 21 and potentially 
alter both Rpb9-AL and AL-TL interactions, causes an upstream shift in transcription 
start site of ADH1, a trait shared by rpb9∆ strains (Braberg et al., 2013) and one that is 
common to mutations that increase the pol II transcription rate (Kaplan et al., 2012). In 
addition, a screen for suppressors of the downstream shift in transcription initiation site 
caused by sua7-1, an allele of the gene that encodes TFIIB, identified an allele of RPB9 
that encodes only amino acids 1-107, possibly disrupting Rpb9-AL interactions, 
specifically the hydrogen bond between Rpb9 S112 and the tip of α-helix 20. 
 
In vivo phenotypes across the Rpb9-AL-TL interfaces 
 
 To address our hypothesized model, we made a series of mutations throughout 
each Rpb9-AL-TL interface that could disrupt potential interactions at the Rpb9-AL-TL  
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10-fold serial dilutions of mutations in Rpb9 (rpb9- (95-97)A), the AL (rpb1- (707-
709)A, R711A) and the TL (rpb1- S1091C) which are at each interaction interface 
described in Fig. 3.6 and in the text. Rpb1 mutations were introduced as in Fig. A1, 
and the Rpb9 mutation was carried on a single-copy plasmid marked with HIS3. 
Strains were growth for 3 days on synthetic media or media with indicated 
concentrations of MPA, and 4 days for rich media with either raffinose or galactose 
and supplemented with antimycin A (1 μg/ mL).   
Figure 3.7: Selected phenotypes of mutations located across the Rpb9-AL-TL 
interfaces 
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interfaces. Mutations were characterized using three phenotypes of rpb9∆ strains, 
decreased growth, hypersensitivity to MPA, and suppression of galactose sensitivity in a 
gal10∆56 background (GalR). The GalR phenotype assesses transcriptional interference 
(Kaplan, 2008). In wild-type cells, GAL10 and GAL7 are located in tandem on 
chromosome II (Greger and Proudfoot, 1998). These genes encode UDP-glucose-4-
epimerase and galactose-1-P uridylyltransferase, respectively, which are required for 
galactose to enter the glycolytic pathway. A small deletion in GAL10 (gal10∆56) 
compromises its major polyadenylation signal, and the resulting read-through 
transcription interferes with transcription initiation at GAL7. This leads to a build-up of 
galactose-1-P, one of the substrates of the uridylyltransferase encoded by GAL7, which 
is toxic to yeast. Toxicity is modulated by certain mutations in pol II (including rpb9∆), 
as well as mutations in pol II elongation factors and mRNA processing factors (Bucheli 
and Buratowski, 2005; Bucheli et al., 2007; Greger et al., 2000; Greger and Proudfoot, 
1998; Kaplan et al., 2005). No specific molecular defect can necessarily be inferred from 
altered galactose sensitivity, but it is a readout directly related to transcription that is 
characteristic of rpb9∆ strains. 
As seen in Fig. 3.7, mutations that are on either side of an interface, i.e. Rpb9-AL 
or AL-TL, exhibit some spectrum of MPAS and GalR. For MPAS, the range is from a 
slight sensitivity in rpb1-R711A, the moderate sensitivity of rpb9- (95-97)A and rpb1-
S1091C, to the well documented hypersensitivity of rpb9Δ(Li et al., 2006; Van Mullem 
et al., 2002). It should be pointed out that the MPA sensitivity exhibited by the rpb9-  
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(95-97)A mutation is unique. Previous studies have indicated that the MPA 
hypersensitivity of rpb9Δ is associated with the first 17 residues of Rpb9, and that 
residues 1-53 can suppress the majority of the MPA sensitivity (Li et al., 2006). The 
MPA sensitivity associated with residues 95-97 may be related to a specific C-terminal 
mechanism of Rpb9 that is TL-dependent, which is intriguing as most transcriptionally 
fast mutations in the TL (Kaplan et al., 2012; Kaplan, 2008), as well as mutations rpb1- 
(707-709)A and S1091C, also share a sensitivity to MPA. In addition, while suppression 
of the gal10∆56 allele seen with the selected mutations in Fig. 3.7 is varied, mutations 
(707-709)A, R711A, and S1091C all have some spectrum of GalR. It is worth pointing 
out that in addition to the mutations in Fig. 3.7 which we chose to study more 
extensively, we also observed various spectrums of decreased growth, GalR, and MPA 
sensitivity phenotypes in the Rpb9 point mutants Q87A and S96A, the AL mutant rpb1-
S713P, and in several mutants (rpb1-V1089∆, S1091C/W, K1092E/W) from a pool of 
Rpb1 TL mutants generously provided to us from the Kaplan Lab (Appendix Fig. 7-9).  
This reinforces our conclusion that mutations that are in each proposed interaction 
interface result in phenotypes shared by rpb9Δ.  
 
Anchor Loop mutations are epistatic with rpb9Δ 
 
 Earlier we had shown that there is a two-fold increase in the misincorporation 
rate for pol II∆9 and for pol II with Rpb9- (95-97)A. Similar to pol II∆9, Rpb9- (95-
97)A also causes a two-fold increase in the average rate of correct nucleotide extension 
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(Appendix Fig. 10A). If the proposed model is correct, then rpb1 mutations at the Rpb9-
AL and AL-TL interfaces that result in phenotypes that are similar to those of rpb9∆ 
strains would be expected to mimic the fast elongation rate of pol II∆9 and Rpb9- (95-
97)A. Using pol II immobilized from WCE derived from cells expressing Rpb1 (707-
709)A, Rpb1-R711A, and Rpb1-S1091C, the rates of A-for-C misincorporation (Fig. 
3.8A) , as well as the average rates of elongation with template-matched NTPs 
(Appendix Fig. 10B), were all essentially identical to the fast rates observed with pol 
II∆9 and Rpb9- (95-97)A (Refer to Table 3.1 for all determined observed rates). In 
addition, just as with pol II∆9 and Rpb9- (95-97)A, the presence of saturating amounts 
of α-amanitin collapsed the misincorporation rate to that observed with wild-type pol II 
(Table 3.1 and Appendix Fig. 11), consistent with the idea that the mutations may be 
affecting a TL-related function.  
 TL mutations that affect the rate of elongation tend to be additive when 
combined. Fast, gain-of-function alleles combined with slow, loss-of-function alleles 
tend to have an elongation rate between the two extremes, while combinations of two 
fast or two slow alleles are many times lethal (Kaplan et al., 2012). In contrast, when we 
combined the fast rpb1 alleles associated with the Rpb9-AL-TL interaction network with 
rpb9∆, the combinations were no faster than the single mutations in the A-for-C 
misincorporation assay (Fig. 3.8B and Table 3.1). This epistasis strongly suggests that 
the defect imposed by the rpb1 alleles R711A, (707-709)A, and S1091C is related 
mechanistically to the defect caused by rpb9Δ and rpb9- (95-97)A.  
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 (A) ATP 1mM was added to ECs immobilized from WCEs with the rpb1- (707-709)A, -
R711A, or S1091C mutation, and the extension of the RNA to 11 nucleotides (nt) or greater 
was monitored over time via a  20% polyacrylamide gel. The fraction extended to 11 nts in A 
was plotted and fit to a single exponential function to obtain an observed rate for 
misincorporation, indicated by each representative assay. (B) The pol II mutations in A were 
combined into a rpb9∆ and challenged with the same misincorporation assay. Rates are 
indicated as in A, and compiled in Chapter III, Table 1.  
Figure 3.8: AL and TL mutations are epistatic in vitro with rpb9∆ for an ATP 
misincorporation 
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Discussion  
 
A mobile element at the core of RNA pol II known as the trigger loop, is 
important for both catalytic coordination and for transcriptional fidelity (Larson et al., 
2012). As discussed in Chapter I, The movement in and out of the active site determines 
the extent to which the TL can fulfil these functions, many of which are conserved both 
in bacterial as well as RNAPs (Kireeva et al., 2012; Wang et al., 2013). In terms of 
transcriptionally fidelity, mutations in the TL which reside in hinging areas based on 
crystal structures, such as the well-studied hinge mutant E1103G, seem to affect not only 
the likelihood of incorporating a mismatched NTP, but also decrease pol II’s ability to 
induce pauses which is important for the proof-reading response (Larson et al., 2012). In 
addition, residues that have been identified as being critical for substrate selection in the 
area of the TL that makes contacts with the substrate NTP, can also be indirectly 
affected by changing the time to which they occupy the catalytic center. Therefore it is 
important for us to understand, not only in terms of pol II mechanism, but also in terms 
of accuracy of transcription, how the TL transition, in and out of the active site, is 
mediated.  
Single-molecule, computational, and bulk biochemical data have pointed to many 
different active site areas as being important for TL mobility. Residues near a C-terminal 
hinge of the (e.g. E1103) , are thought to be important for stabilizing the open TL 
conformation, and many mutations in this region have a characteristic increase in 
elongation rate both for matched and mismatched substrates  
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(Kaplan et al., 2012; Kaplan, 2008; Kireeva et al., 2008; Walmacq et al., 2009). In 
contrast, residues in the nucleotide interacting region of the TL are thought to stabilize 
the closed conformation of the TL in addition to their functions in coordinating catalysis  
(Kaplan, 2008; Wang et al., 2015) (Refer to Fig. 1.4). In is interesting that, in addition to 
fidelity, transcriptional start site selection also seems to be a biochemical read-out for TL 
mutations (Jin and Kaplan, 2015; Kaplan et al., 2012). An upstream shift is observed for 
fast mutations such as E1103G, while a downstream shift is observed for slow mutations 
such as H1085Y.  
A small subunit at the leading edge of pol II, Rpb9, was also suggested to affect 
the TL transition through its C-terminal domain based on its similarities with the rpb1- 
E1103G mutation. Similarities included an increase NTP-sequestration, 
misincorporation rate, and upstream shift in start site (Walmacq et al., 2009). However 
direct biochemical analysis of a mutation in the proposed interaction pathway yielded a 
negative result. Previous data from our lab as well as others have implicated Rpb9 in 
transcription fidelity as well as a host of other functions (surveyed in Chapter I), 
however we were curious to know if some function of Rpb9 was indeed TL-dependent. 
To determine this, we took advantage the TL inhibitor α-amanitin, and with it were able 
to show that this increase in misincoroporation rate associated with a rpb9Δ is dependent 
on free movement of the TL (Fig. 3.1) 
Other residues extrinsic of the TL have been suggested by multiple molecular 
dynamic studies that considered residue conservation, and attempted to model the TL 
transition pathway via published crystal structures of bacterial and yeast RNAP (Kireeva 
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et al., 2012; Wang et al., 2015; Wang et al., 2013). In S. cerevisiae, residues such as 
E712 (TL counter-part K1092) and K726, which are located on a loop and adjoining α-
21 in Rpb1 subunit of pol II, have been suggested to affect multiple states of the TL. 
Though, no biochemical evidence until our study has confirmed this. Interestingly, these 
residues are in close proximity to the sit1 mutation, rpb1-G730D which we and others 
have biochemically characterized and found to be suppressive of certain phenotypes of 
fast elongation TL mutations as well as the loss of pol II subunit Rpb9 (Appendix Fig. 2) 
(Koyama et al., 2010; Walmacq et al., 2012). This same mutation allowed us to take an 
unbiased approach to identify mutations that might be important for Rpb9 function. 
As seen in Fig. 3.3 and 3.4, one mutation in particular rpb9- (95-97)A was 
identified through this approach. This Rpb9 variant mimic the behavior of a rpb9Δ in 
both a misincorporation assay, and for correct nucleotide extension. We also found that 
the increase in observed rate for misincorporation for Rpb9- (95-97)A was likewise 
dependent on the TL via α- amanitin (Fig. 3.4). This caused us to scrutinize the 
published crystal structures available and propose an alternate model for how Rpb9 C-
terminal domain might affect TL mobility.  Here we suggest an indirect pathway of how 
Rpb9 affects the TL via a loop connecting α-20 and -21 which we have termed, the 
anchor loop. We posit that stabilization of the open conformation of the TL via contacts 
in the AL is partially coordinated by the C-terminal domain of Rpb9 through residues 
95-97. This is in contrast to the suggested direct interaction pathway for Rpb9, for which 
there is no evidence, and would provide an explanation for previous biochemical results, 
as wells as our own results for TL-dependent function of Rpb9 (Walmacq et al., 2009).  
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We began testing our model by phenotyping mutations at each proposed 
interface:  Rpb9 and the AL, and the AL and the TL. Based on our model, we reasoned 
that if these interface residues were important for the function of Rpb9, they should 
exhibit phenotypes of rpb9∆. Indeed, when we challenged mutations at our proposed 
interfaces in vivo, we found that many of them modulated certain phenotypes of an rpb9 
null such as MPA sensitivity, decreased growth, and the GalR phenotypes (Fig. 3.7 and 
Appendix Fig. 7-9). In vitro analysis of selected AL mutations such as rpb1-R711A, 
(707-709)A, and the TL mutation rpb1-S1091C revealed an increased misincorporation 
and matched nucleotide elongation rate, similar to that of rpb9∆. And critically, these 
same mutants increased misincorporation rate were also dependent on the presence of α- 
amanitin (i.e. TL mobility) and were no faster in combination with rpb9∆ (Fig. 3.8 and 
Appendix Fig. 10-11). This provides strong evidence for our suggested model.  
Interestingly, the selected mutations in Rpb9, AL, and TL are also consistent 
with a previously described TL mutation, rpb1-G1097D, which is located proximal to 
the C-terminal hinge portion of the TL, transcriptionally fast, and has a strong GalR 
(Kaplan et al., 2012; Kaplan, 2008). The typical trend for previously published 
mutations in the TL, mutations that are posited to affect TL mobility and catalysis, is a 
concomitant MPA sensitivity with increased elongation rate (Kaplan et al., 2012; 
Kaplan, 2008). The GalR phenotype however, generally is associated with slower 
mutations in the TL region, making the mutations in Fig. 3.7 unique along with G1097D. 
Interestingly, neither R711A, (707-709)A, or S1091C is synthetic lethal with rpb9Δ, 
whereas G1097D is (Appendix Fig. 1). A previous study that analyzed combinations of 
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mutations in the TL that had opposite effects, i.e. combinations that combined a 
transcriptionally fast mutation with a transcriptionally slow mutation, found that the 
mutant combinations are normally additive (Kaplan et al., 2012). In the same study, 
mutation combinations that had similar defects are normally inviable. We have 
demonstrated that the defect of Rpb9- (97-97)A is TL-dependent and mutations analyzed 
in this chapter all share some spectrum of rpb9Δ phenotypes. Given that the same 
mutations are not lethal in combination with rpb9Δ and are epistatic in their in vitro 
effects in our assays, these data seem to suggest the possibility that these mutations may 
be upstream defects, consistent with our model.  
This would also be consistent with our observation that the Rpb9- (95-97)A 
variant is not synthetically lethal with either rpb1-E1103G or rpb1-L1101S (Appendix 
Fig. 13). If the AL in conjunction with Rpb9 serves to stabilize the open conformation of 
the TL, then the most upstream defect in our proposed pathway, is intrinsic changes 
within the hinges of the TL. In addition, we can also interpret Rpb9- (95-97)A 
interaction with TL mutations such as E1103G and L1101S, given the fact that full 
length Rpb9 is present in conjunction with the TL mutations. We have already seen that 
the first N-terminal 59 amino acids of Rpb9 suppress most of the in vivo phenotypes 
caused by the lack of Rpb9. However, it has also been shown that C-terminal truncation 
mutant of Rpb9 (Rpb9 1-53) has significantly reduced association with pol II (Chen et 
al., 2007). Even though mutation of residues 95-97 in Rpb9 increase the transcription 
rate, they do not affect the contribution of Rpb9 function through the N-terminal domain. 
Therefore rpb9- (95-97)A is simply epistatic with TL hinge mutations whereas Rpb9 (1-
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59) is synthetic lethal because reduced function of the N-terminal domain by decreased 
association, and loss of the C-terminal domain (Appendix Fig. 13). In addition, it could 
hint that in addition to the transcriptional role we have observed in the above data, the C-
terminal domain of Rpb9 may also have another important role. Certainly, the proximity 
of the AL and the C-terminal domain of Rpb9 to where the extrinsic factor TFIIS and the 
transcription factor Bye1 bind the jaw domain of pol II provide intriguing targets for 
analysis (Discussed more in Chapter IV).  The interaction of these factors, especially 
TFIIS, may become more important given the documented role of Rpb9 in proofreading 
(Knippa and Peterson, 2013).   
The results in this chapter argue for a TL-dependence for a portion of Rpb9 
function, and provide a novel interaction pathway of how Rpb9 mediates its effect on 
active site processes through the so-called AL. Mutations in the residues 95-97 in Rpb9, 
as well as mutations in the AL and corresponding TL residues, provide evidence that the 
AL is directly important for the TL open conformation. This was ascertained by the in 
vitro epistasis of the mutations in combination with rpb9∆ for misincorporation 
experiments, as well as their increased misincorporation rate dependence on α-amanitin. 
In vivo behavior of mutations at each interaction interface of our model also exhibit 
varying degrees of phenotypes associated with the loss of Rpb9 are also consistent with 
our model, as well as molecular dynamic studies that have predicted the effects of 
mutations in the AL regions on TL transitions (Kireeva et al., 2012; Wang et al., 2015; 
Wang et al., 2013).   
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CHAPTER IV 
RPB9 N-TERMINAL DOMAIN 
 
Summary  
 
Rpb9, a small non-essential subunit of RNA polymerase II (pol II), has been 
shown to affect pol II activity in several ways. These functions include a role in the 
modulation of TL mobility and effects on the TFIIS-mediated proofreading function of 
pol II. As described in Chapter III, the TL-dependent function of Rpb9 is likely mediated 
through its C-terminal Zn2 domain. Compared to the C–terminal domain, much less is 
known about the function of the N-terminal domain of Rpb9. Numerous genetic 
interactions between Rpb9 and chromatin-related complexes have been reported that are 
not easily explained based on what is known about the function of Rpb9. In this chapter, 
I describe preliminary experiments that suggest these genetic interactions are related to a 
function of the Rpb9 N-terminal domain. These experiments demonstrate that the first 
~10 amino acids of Rpb9 are critical to cell viability in the absence of genes encoding 
SAGA complex components Gcn5 or Spt7, the histone variant H2A.Z, or Swc5, an 
integral component of the SWR1 complex, which substitutes H2A.Z for H2A in selected 
nucleosomes. Loss of the same amino acids has an additively negative phenotype with 
the loss of Bye1, a protein that has been proposed to displace TFIIS at nucleosomes and 
is important for induction of stress related genes. This suggests that there are at least two 
pathways in which Rpb9 can affect the passage of pol II through nucleosomal templates. 
 77 
 
One pathway involves the N-terminal domain and may be related to the role of Rpb9 in 
recruiting TFIIF to pol II, and the second involves the C-terminal domain and may be 
related to a role for Rpb9 in the binding of Bye1 to pol II, which is mutually exclusive 
with the presence of TFIIS. 
 
Introduction  
 
 Rpb9 is composed of three distinct domains, two of which share a structural 
motif common to several subunits of pol II, the zinc-ribbon fold. They are the N-
terminal Zn1 domain, the central linker region, and the C-terminal Zn2 domain. As 
overviewed in Chapter I and discussed in more detail below, different Rpb9 domains 
have been implicated in various functions in the cell. The context in which all structural 
domains of Rpb9 have been studied the most has been transcriptional fidelity. Indeed, 
Chapter III showed that the C-terminal domain of Rpb9 seems to communicate with the 
active site of pol II through a molecular pathway that passes through the AL in order to 
reach the TL. However, the mechanism of Rpb9 in functions other than transcriptional 
fidelity have remained elusive. This is especially true for various interactions that have 
been documented with Rpb9 and chromatin-related co-transcriptional complexes.  
 
Rpb9 C-terminal domain 
 
Rpb9 has been implicated in several functions in addition to its role in TL  
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mobility described in Chapter III. Though there are homologs of Rpb9 in the two other 
nuclear polymerases (C11 in RNA pol III and A12.2 in RNA pol I), the C-terminal 
domain of Rpb9 is somewhat different in that it cannot stimulate cleavage, but rather 
depends on the extrinsic factor TFIIS. Indeed, replacing the Zn2 domain of Rpb9 with 
that of with C11, which contains an acidic hairpin loop similar to that of domain III of 
TFIIS, allows pol II to gain the ability to strongly stimulate cleavage, in contrast with the 
normal intrinsic cleavage of pol II, which is minimal (Cabart et al., 2014; Kettenberger, 
2003; Qian et al., 1993; Ruan, 2011). This has been suggested to be an explanation for 
why C11 is an essential protein and perhaps another layer of control that pol II has 
gained to control cleavage activity. However, Rpb9, though not directly responsible for 
activity, does affect TFIIS-mediated cleavage (Knippa and Peterson, 2013).  In addition, 
the Rpb9 C-terminal domain has been implicated in UV-mediated Rpb1 degradation in 
pathways independent of any Nuceotide Excision Repair pathways (NER) (Chen et al., 
2007). Specifically, it was shown that the Rpb9 Zn2 domain is important for Rpb1 
ubiquitinylation and subsequent degradation by the 26S proteasome when pol II stalls at 
sites of DNA damage. The model suggested was that Rpb9 Zn2 was necessary for either 
sensing of transcriptional senescence or recruitment of degradation factors necessary to 
remove pol II so that DNA repair can take place and transcription can resume. The C-
terminal domain and linker have also been reported to directly interact with the Tfa1 
subunit of the basal transcription factor TFIIE in a yeast two-hybrid assay (Van Mullem 
et al., 2002), but the functional significance of this interaction has not been investigated.  
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Rpb9 N-terminal domain 
  
 In contrast to the C-terminal domain, much less is known mechanistically about 
the N-terminal domain (Zn1) of Rpb9. Yet, several interesting phenotypes of rpb9∆ 
yeast strains can be suppressed by supplying only the Zn1 domain of Rpb9. Several 
studies have indicated that the first 45 to 57 amino acids of Rpb9 can suppress, in some 
cases completely, the severe growth defect (Awrey, 1997; Hemming and Edwards, 2000; 
Hemming et al., 2000; Koyama, 2007; Li et al., 2006; Van Mullem et al., 2002) and the 
hypersensitivity to mycophenolic acid (MPA) (Li et al., 2006) associated with rpb9∆ 
strains. This is intriguing, as mutations in pol II exhibiting MPA sensitivity normally are 
transcriptionally fast mutations (Jin and Kaplan, 2015). The sensitivity associated with 
the N-terminal domain of Rpb9 seems to be much stronger compared to the sensitivity to 
MPA observed for C-terminal mutations that we have measured to be transcriptionally 
fast (see Fig. 3.2). Additionally there is no evidence that N-terminal Rpb9 mutations are 
transcriptionally fast, and the MPA hypersensitivity seen in the truncations of the N-
terminal domain of Rpb9 may be derived from some other type of defect. It is interesting 
to note that the MPA hypersensitivity of rpb9∆ can be mimicked by mutating the 
coordinating cysteines in the Zinc-ribbon fold of the N-terminal domain (Li et al., 2006). 
In addition, specific regions of Rpb9 have been shown to be important for association of 
Rpb9 to pol II. For example, deletion of more than the first 17 amino acids or deletion of 
the charged residues 65-70 abolished Rpb9 association as measured by a tag pull down 
assay (Hemming and Edwards, 2000). However, many studies, including experiments to 
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be presented here, indicate that only the first 59 amino acids of Rpb9 are required to 
suppress many of the phenotypes of rpb9∆ strains (Chen et al., 2007; Hemming and 
Edwards, 2000).  
 Several interesting questions arise concerning the N-terminal domain of Rpb9. 
Can the N-terminal domain alone suppress the synthetic lethality associated with a host 
of chromatin-related proteins (Table 4.1) and for which there has been no mechanistic 
interpretation for their interaction with Rpb9? If it is sufficient, what specific residues in 
the N-terminal domain are important for mediating the interaction between Rpb9 and the 
particular chromatin modifying protein? Are these interactions direct or indirect (i.e., are 
the chromatin modifying complexes directly interacting with Rpb9, or is there a 
mediator between them)?  
 
Introduction to Bye1 
 
 Bye1 (Bypass of ESS1) is a nuclear protein in S. cerevisiae that was originally 
isolated as a multi-copy suppressor of mutations in ESS1, which encodes a peptidyl-
prolyl isomerase important for pol II CTD conformation, polymerase pausing, and 
transcription termination (Hani et al., 1995; Morris et al., 1999; Wu et al., 2003). More  
specifically, it was shown that overexpression of Bye1 could suppress the temperature 
sensitivity of ess1∆, but not its increase in pause site read-through or its transcription 
termination defect (Wu et al., 2003). More recently, it has been shown that Bye1 has a  
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Table 4.1: Synthetic lethal genetic interactions with rpb9∆ 
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domain homologous to that of domain II of TFIIS that is required for the binding of 
TFIIS to the “jaw” domain of pol II (Cheung and Cramer, 2011). This is unique, as there  
are no other proteins in budding yeast that share this TFIIS-like domain, and, as with 
TFIIS, the domain is required for Bye1 to associate with the Rpb1 subunit of pol II 
(Kinkelin et al., 2013; Pinskaya et al., 2014; Wu et al., 2003). Bye1 contains two 
domains in addition to its central TFIIS-like pol II binding domain and N-terminal 
nuclear localization signals. The N-terminal Plant Homeo Domain (PHD) is generally 
associated with proteins that bind chromatin, and it is important for binding to 
methylated lysines on histone tails (Aasland et al., 1995).  Bye1 was recently shown to 
be associated within the gene bodies of actively transcribed pol II and pol III genes, as 
well as a much smaller subset of pol II promoter regions. Not surprisingly, the 
localization of Bye1 to promoters, but not gene bodies, is dependent on the binding of 
the PHD domain directly trimethylated H3K4 residues (Aasland et al., 1995; Kinkelin et 
al., 2013). The flanking SPOC (Spen paralogue orthologue C-terminal) C-terminal 
domain is the third domain of Bye1. The SPOC domain’s role in S. cerevisiae is not well 
understood. However, in H. sapiens, it has been shown to be important for subunit 
interactions in transcriptional repression complexes that are critical for cell-signaling 
pathways, and it may be related to the development of a specific subtype of leukemia 
(Ariyoshi and Schwabe, 2003; Lee and Skalnik, 2012).  
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Bye1 in vivo 
 
 Genome-wide occupancy analysis, along with various in vivo and in vitro studies, 
have combined to increase the understanding of Bye1’s function (Braberg et al., 2013; 
Kinkelin et al., 2013; Pinskaya et al., 2014). Studies have shown that, over expression of 
Bye1 in yeast lacking DST1 (the gene encoding TFIIS) enhances the sensitivity of dst1∆ 
cells to 6-azauracil (Wu et al., 2003). In addition, it was reported that the sensitivity of 
dst1∆ cells to high concentrations of caffeine and NaCl, which can affect cell wall 
integrity, is enhanced in the bye1∆dst1∆ double mutant and is even more severe at 
higher temperatures (34oC) (Kinkelin et al., 2013). This suggests two different modes of 
action for Bye1: one that opposes TFIIS, as seen through the increase of the dst1∆ 
phenotype with the over expression of Bye1; and the other that is potentially parallel 
with TFIIS, based on the additive effects of deleting both genes under certain stress 
conditions. In addition, bye1∆ also demonstrates severe synthetic growth defects in 
combination with the deletion of Paf1 and Tho2 (Kinkelin et al., 2013). Paf1 is a 
component of the 5 subunit Paf1C complex, which is required not only for the 
recruitment of the histone methyltransferase Set1 to active genes, but also for 
ubiquitylation of H2B (Sen et al., 2013). Once present at chromatin templates, Set1 is 
responsible for trimethylating the K4 residues of H3 tails. Tho2, on the other hand, is a 
component of the THO complex, which is important for elongation through DNA 
templates containing tandem repeats, as well as shuttling mRNA from the nucleus to the 
cytoplasm (Betz et al., 2002; Krogan et al., 2003; Tong et al., 2004). Both Paf and THO 
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complexes affect the overall efficiency with which pol II can transcribe through a gene 
body (Costa and Arndt, 2000; Jimeno et al., 2011). Interestingly, SPOC domains have 
been shown to interact with Set-domain-containing proteins suggesting that Bye1 may 
recruit complexes (such as Paf) to chromatin by binding H3K4 tails via its PHD domain 
and recruiting accessory complexes via its SPOC domain (Lee and Skalnik, 2012). 
 ChIP-chip, as well as conventional ChIP experiments, have outlined several 
different classes of Bye1 chromatin occupancy in vivo (Pinskaya et al., 2014). First, 
Bye1 is associated with actively transcribed pol II genes, concomitant with the presence 
of pol II and TFIIS. A second class of Bye1 association is found on pol III class genes 
together with TFIIS. Third, there was observed a localization of both TFIIS and Bye1 
just outside of the telomeres, again absent of pol II. And finally, there was an enrichment 
of Bye1 at certain pol II promoter regions with active, albeit lower, levels of pol II 
activity. For the localization of Bye1 at both classes of pol II promoters, there is a direct 
dependence on H3K4 trimethylation mediated through Set1, as well as active 
transcription of the gene. However, the localization of Bye1 to coding regions of pol II 
genes requires only active transcription, but not the H3K4 methylation mark. 
Interestingly, in both cases Bye1 is co-immunoprecipitated with TFIIS by pol II 
antibodies, suggesting a potential equilibrium between the binding of TFIIS and the 
binding of Bye1 (which are mutually exclusive) during active transcription.  
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Bye1 in vitro 
 
 In vitro experiments along with a recent crystal structure of the Bye1 TLD 
(TFIIS-Like Domain) have shed some light on more specific Bye1 activities. As 
discussed above, the TLD domain of Bye1 is absolutely required for association with the 
jaw domain of Rpb1, similar to TFIIS, as determined by co-immunoprecipitation and 
yeast two-hybrid screening (Pinskaya et al., 2014). From the co-crystal structure 
however, there are some differences between the binding of Bye1 and TFIIS. First, as 
pointed out in Kinkelin et al. and seen in Fig. 4.1, in contrast to TFIIS domain II, the 
linker of Bye1’s (α6) TLD domain makes contacts with the AL between residues 703-
706 (Specifically there is a hydrogen bond between H706 in the AL and N362 in Bye1, 
indicated as a red star in Fig. 4.1C), which changes conformation depending on whether 
Bye1 or TFIIS is bound (Kinkelin et al., 2013). This is intriguing given the role of the 
AL in TL mobility, and it is possible that Bye1 could affect pol II elongation via this 
interaction. Second, there are contacts between the N-terminal domain of Rpb5 and a 
loop located between α3 and α4 of Rpb1. Also seen in Fig. 4.1C, is the proximity of the 
Rpb9 N-terminal domain which forms a β sheet between Rpb1 residues 1148-1154 
(indicated with a red star). Because of the lack of an ordered N-or C-terminal domain of 
Bye1 in the crystal structure, it is hard to speculate on their spatial location. However, 
the N-terminal PHD domain would be in the general vicinity of the leading edge of pol 
II, where it potentially contacts histones tails. In addition, unlike domain III of TFIIS 
which is directly responsible for RNA transcript cleavage and accesses the active site of  
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Structures (A) (top view) and (B) are S. cerevisiae 12-subunit RNA polymerase II 
(PDB 4bxz for structures containing Bye1 or 1Y1V for structures containing TFIIS). 
Different colors indicate different domains or subunits of the polymerase. (C) A 
zoom-in portion of the polymerase structure depicted in the previous figure 
illustrating the Bye1 TLD and integral helices (green). Red stars indicate specific 
interactions between Rpb9 and Rpb1 lobe (residues 1148-1154) or the Anchor Loop 
(purple) (see text for details). (D)The analogous representation of TFIIS from 1Y1V 
indicating its position in terms of the same pol II local area.  
Figure 4.1: Crystal structure of RNA polymerase II with Bye1 and TFIIS 
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pol II by inserting into the funnel domain of pol II, the arrangement of the SPOC domain 
at or near the funnel domain is unclear (Ruan, 2011), though, it seems unlikely that it 
competes for active site occupancy with the TL.   
 Experiments that directly probe the effect of Bye1 on pol II activity have been 
performed; however, the results are somewhat qualitative in nature. One set of 
experiments looked at Bye1’s effect on pol II in the context of a Gcn4-dependent 
promoter template with pol II derived from cells lacking Bye1 (Kinkelin et al., 2013). In 
this assay pol II activity was present with and without Bye1 in the presence of the Gcn4 
activator. However, only an end-product was monitored only at a single end-point, 
therefore potential effects of Bye1 on elongation or pausing remain unclear. Similarly, a 
second set of experiments, which looked at purified pol II assembled into an elongation 
complex similar to those described in Chapter II, demonstrated that pol II activity with 
or without the addition of purified Bye1 remains unaffected. In addition, no formation of 
cleavage products or backtracking was detected, even after the addition of a 100 fold 
excess of purified Bye1, in contrast to the addition of stoichiometric amount of TFIIS. 
These experiments again measured only a single end-point, so effects on rate would not 
have been observed. Thus, there are unanswered questions concerning the possible 
competition between Bye1 and TFIIS for pol II binding or effects of Bye1 on pol II 
activity.  
 Given current known functions of Bye1 and its location above the N-terminal 
domain of Rpb9, it is intriguing to consider a possible model for how Rpb9 relates to 
chromatin modifying complexes. Perhaps Rpb9, given its structural location at the 
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leading edge of pol II, helps form a scaffold along with residues of Rpb1 so that Bye1 
can efficiently bind the polymerase complex and interact with histone tails on incoming 
nucleosomes. In this chapter, I attempt to probe a possible role for Rpb9 and chromatin 
modifying complexes based on the synthetic lethal interaction between rpb∆ and 
deletions of genes that code for protein components of those complexes. In addition, I 
also explore the potential relationship between Rpb9 and Bye1 to help shed light on the 
interactions between pol II and various chromatin modifiers that could be mediated 
through Rpb9, whether directly or indirectly.  
 
Results 
 
Rpb9 N-terminal domain is required for viability in cells lacking Gcn5, H2A.Z, or Spt7 
 
As noted in Chapter I, Rpb9 is positioned at the leading edge of the polymerase, 
the N-terminal domain being the leading most structural element (Fig. 4.1C). Deletion of 
RPB9 is synthetically lethal with deletions of genes encoding components of several 
chromatin remodeling complexes, including the Paf1 and SAGA complexes, which are 
indirectly and directly responsible for histone modifications, respectively. It is therefore 
easy to imagine that Rpb9 somehow mediates interactions between histones and the core 
of pol II as the polymerase traverses through chromatin-laden templates. This mediation 
need not be direct, as the body of pol II is a dynamic landscape for associations with 
many different complexes. Rather, Rpb9 could, in conjunction with other pol II subunits 
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or associated factors, help stabilize association of the chromatin modifying complexes.  
Independent of the molecular details, we wondered if the N-terminal domain of Rpb9 
would be sufficient to suppress the synthetic lethality of rpb9∆ and deletions of genes 
encoding components of chromatin-modifying complexes. In addition, knowing that the 
C-terminal domain can affect TL mobility, we were also curious to see if there were 
specific genetic interactions with C-terminal Rpb9 mutations, as it has been shown that 
TL mutants that confer a transcriptionally fast phenotype are synthetically lethal or 
additively synthetic sick with mutations in components of certain chromatin-modifying 
complex components (Braberg et al., 2013; Jin and Kaplan, 2015). Specifically, is was 
shown that the combination of the TL mutation E1103G and the loss of the SAGA 
complex catalytic component Gcn5 are synthetically lethal (Braberg et al., 2013). 
Our experimental strategy was to form a haploid shuffle strain in budding yeast 
which lacked Rpb9 and the synthetic lethal gene of interest in the genome, but was 
supplemented with a URA3 marked plasmid-born copy of wild-type RPB9. Then using a 
standard plasmid shuffle strategy (See Chapter II Methods), we could test a set of Rpb9 
variants for suppression of synthetic lethality. We chose three different genes (GCN5, 
HTZ1, and SPT7) from Table 4.1, all of which are associated with chromatin 
modification and, when deleted, are synthetically lethal with rpb9∆. Gcn5 and Spt7 are 
components of the SAGA complex and have been shown to interact with pol II subunits 
Rpb1-3 and Rpb5 in yeast two-hybrid assays, and together within the SAGA complex 
function in both negative and positive roles in pol II dependent transcription 
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(A) Background yeast strains created by cross containing a deletion of Rpb9 and one 
of the selected genes from Table1 are supplemented with a wild-type copy of Rpb9 
(pRpb9) on a centromeric plasmid marked with URA3. Replica-plating cells onto 
media containing 5-FOA will result in lethality for cells requiring Rpb9 contained on 
the URA3 plasmid (B) In addition to carrying wild-type Rpb9 marked with URA3, 
cells were transformed with variants of Rpb9 on a centromeric plasmid marked with 
HIS3 indicated above the panels. Cells were then replica-plated on media containing 
5-FOA to determine which Rpb9 variants would suppress the synthetic lethality.   
Figure 4.2: Rpb9 C-terminal mutants can suppress synthetic lethality associated 
with the combination of rpb9Δ with gcn5Δ, htz1Δ, or spt7Δ 
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(Garcia-Oliver et al., 2012; Rodriguez-Navarro, 2009; Van Mullem et al., 2002; Wery et 
al., 2004). Gcn5 is the catalytic component with a histone acetyltransferase activity, 
while Spt7 is required for formation and stabilization of the complex (Bonnet et al., 
2014; Grant et al., 1997; Rodriguez-Navarro, 2009; Spencer, 1989; Sterner et al., 1999). 
HTZ1 codes for the histone H2A.Z variant, which is preferentially enriched in promoter-
proximal nucleosomes and is important for pol II nucleosome clearance by efficient 
nucleosome remodeling and proper pol II elongation complex assembly (Jensen et al., 
2011; Santisteban et al., 2011; Santisteban et al., 2000; Wan et al., 2009).  Also selected 
was a variety of Rpb9 mutations that span the N- and C-terminal domains of Rpb9 (Fig. 
4.2B). These include the C-terminal, transcriptionally fast Rpb9 (95-97)A variant and 
the variant Rpb9 (1-59) which includes the complete N-terminal domain only. As seen in 
Fig. 4.2B (SC-5 FOA rows), all of the selected Rpb9 variants were able to suppress the 
synthetic lethality in gcn5Δ, htz1Δ, and spt7Δ backgrounds. Importantly, the N-terminal 
Zn1 domain of Rpb9 is sufficient for suppression in every case, suggesting that the 
relevant portion for the interaction between RPB9 and GCN5, HTZ1, and SPT7 is 
contained within the N-terminal 59 amino acids of Rpb9. It should also be noted that we 
did not observe a synthetic lethal interaction with the Rpb9 (95-97)A and gcn5Δ as we 
might have predicted based on the interaction between the TL mutation E1103G and 
gcn5Δ (Braberg et al., 2013). Perhaps this difference reflects two different modes of 
altering the TL’s effect on catalytic rate similar to what has been suggested by single-
molecule work by the Bustamante lab (Mejia et al., 2015).  
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Rpb9 C-terminal mutations interact differently in a gcn5/spt7Δ background versus htz1Δ  
 
To better characterize the extent of the suppression shown in Fig. 4.2, we made 
10-fold serial dilutions on various media. We spotted cells on minimal media (SC-His), 
media containing MPA (in pol II TL mutants seems to related to catalytic speed and 
transcriptional start site) (SC-His + MPA), and rich media (YPD) (Figs. 4.3-4.5)  
(Kaplan et al., 2012). In all cases, Rpb9 (1-59) had the most severe growth phenotype 
out of all the Rpb9 variants tested, though it was never more severe than either single 
mutant background. However, it should be noted that Rpb9 (1-59) is sufficient to 
complement the synthetic lethality, and in some instances, can complement a majority of 
the growth defect in the rpb9Δ single mutant (refer to Fig. 3.2). This lack of complete 
phenotypic suppression may be related to the reduced association of the Rpb9 (1-59) 
variant, as there is evidence that similar truncations result in decreased affinity (Chen et 
al., 2007; Hemming and Edwards, 2000). With respect to the gcn5Δ/Rpb9 combinations, 
there is a negative interaction for Rpb9 (88-97)Δ, but not for any other C-terminal 
mutations both for growth on minimal media and on media containing MPA (Fig. 4.3, 1st 
and 2nd column of panels). However combinations of Rpb9 variants with deletion of its 
SAGA complex counterpart Spt7, show no significant interaction with any C-terminal 
Rpb9 mutations (Fig. 4.5). These epistatic interactions with the C-terminal Rpb9 
mutants, particularly the biochemically characterized Rpb9 (95-97)A variant, could  
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SC- His SC- His + 10μg/mL 
MPA 
YPD 
Ten-fold serial dilutions of strains isolated from shuffles from previous figure or 
single deletion control strains carrying vector only (pRS413). Strains were spotted on 
minimal media (left panels), media containing 10μg/mL MPA (middle panels), or rich 
media (right panels). Pictures shown are after 3 days of growth.  
Figure 4.3: C-terminal mutations in a gcn5Δ background 
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suggest a potential role for the Rpb9 C-terminus in pol II enzymatic activity, combined 
with evidence in the literature that lack of Gcn5 affects pol II elongation in certain G- 
less templates (Tous et al., 2011). Additionally, it should be pointed out that the loss of 
Gcn5 does not affect the overall stability of the SAGA complex (Grant et al., 1997; 
Spencer, 1989; Sterner et al., 1999). This argues that the synthetic interactions that we 
observe between the loss of Rpb9 and either Gcn5 or Spt7, may directly or indirectly 
depend the histone acetyltransferase activity of SAGA rather than some function that 
requires direct interaction with the Rpb9 N-terminal domain. 
In an htz1Δ background, we see a larger contrast in mutant effects with Rpb9 C-
terminal mutations. On minimal media (Fig. 4.4, left panels), every Rpb9 variant showed 
a growth defect similar to an htz1Δ or rpb9Δ alone.  However on rich media, we see both 
additive and suppressive interactions. For mutations in residues 95-97, or the mutation 
(88-90)A, or complete loss of the C-terminal domain (1-59) of Rpb9, there is an additive 
effect with the loss of H2A.Z. However, with the mutations (91-94)A and (88-97)Δ, we 
observed suppression of either single mutant phenotype. Interestingly, the sensitivity to 
MPA appears to be suppressed by mutations in residues 95-97 of Rpb9, but Rpb9 (91-
94)A and (88-97)Δ appear to have a phenotype similar to wild-type Rpb9 or the htz1Δ 
single mutant (Fig. 4.5 middle panels). It is difficult to interpret these preliminary data 
given the lack of biochemical data on all of the variants of Rpb9. The one biochemically 
characterized variant is Rpb9 (95-97)A. This mutation in combination with the loss of 
H2A.Z appears to be additively negative. This suggests that the Rpb9 N-terminal domain 
and H2A.Z are important for a pathway that is unrelated to the defect in speed caused by  
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Figure 4.4: Rpb9 C-terminal mutations in a htz1Δ background 
Ten-fold serial dilution of strains containing Rpb9 C-terminal mutations derived from 
plasmid shuffle in an htz1Δ background (as in previous figure). Strains were spotted 
on minimal media (left panels), media containing 10μg/mL MPA (middle panels), or 
rich media (right panels). Pictures shown are after 3 days of growth.  
SC- His 
SC- His + 10μg/mL 
MPA YPD 
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Figure 4.5: Rpb9 C-terminal mutations in a spt7Δ background 
Ten-fold serial dilution of strains containing Rpb9 C-terminal mutations derived from 
plasmid shuffle in a spt7Δ background (as in previous figure). Strains were spotted on 
minimal media (left panels), media containing 10μg/mL MPA (middle panels), or rich 
media (right panels). Pictures shown are after 3 days of growth.  
SC- His 
SC- His + 10μg/mL 
MPA YPD 
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Rpb9 (95-97)A. This would be consistent with experiments showing additive effects in 
combinations of transcriptionally fast TL mutations like E1103G and htz1Δ, as well as 
other chromatin modifying complex components (Braberg et al., 2013).     
 
Rpb9 residues 1-11 are important for cell viability in the absence of Gcn5, H2A.Z, Spt7, 
or the SWR1 complex structural component, Swc5 
 
It has previously been shown that deleting the first 11 amino acids of Rpb9 
mimics the MPA sensitivity of Rpb9 null cells (Li et al., 2006). We wondered if this 
MPA sensitivity was reporting on a function of Rpb9 associated with these chromatin 
modifying complex components, and distinct from the MPA sensitivity associated with 
pol II mutants that have an increased transcription rate. In order to test this idea and 
better define structurally the interaction of the Rpb9 N-terminal domain with various 
proteins important for chromatin remodeling, we combined truncation alleles of RPB9 
that deleted 5 amino acids at a time from the N-terminus of Rpb9 with cells lacking 
Gcn5, H2A.Z, and Spt7. As seen in Fig. 4.6 (from an experiment performed by A.M. 
Wadle in our lab), when we shuffled in variants lacking 5, 10, or 15 amino acids from 
the Rpb9 N-terminal domain, deletion of the first 10 amino acids is sufficient to fully 
restore the synthetic lethality that we previously observed with deletion of rpb9∆ and 
gcn5Δ, htz1Δ, and spt7Δ, as does the longer 2-16 deletion.  It is a possibility that deletion 
of the first 11 residues of Rpb9 affects the fold of the entire Zn1 domain, as this variant 
of Rpb9 removes two of the 4 zinc-coordinating cysteines. Interestingly, there seems  
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Figure 4.6: Rpb9 N-terminal truncations with gcn5Δ, htz1Δ, spt7Δ, or swc5Δ 
backgrounds 
Plasmid shuffle with Rpb9 N-terminal mutants lacking 5, 10, or 15 amino acids from 
the methionine start in gcn5Δ, htz1Δ, spt7Δ, or swc5Δ backgrounds. Plasmid shuffle 
was done similar to the one done with Rpb9 C-terminal mutants earlier in Chapter IV 
(Also see Chapter II).  
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to be an additively negative but not lethal interaction with the 2-6 deletion as well which 
leaves these cysteines unaffected. Nevertheless, these results suggest that for all three 
gene deletions, the first ~11 amino acids of Rpb9 are critical. Since Gcn5 and Spt7 
represent a catalytic and a structural function within the SAGA complex respectively, 
and when deleted have the same outcome with loss of the first 10 residues of Rpb9, we 
similarly wondered if the interaction between Rpb9 and H2A.Z could be recapitulated by 
deleting a component of the SWR1 complex which is required to insert H2A.Z into 
nucleosomes. The subunit in SWR1 complex we chose to delete was Swc5. Swc5 is a 
subunit essential for the function of the SWR1 complex, but is not the subunit which 
carries out the exchange of the H2A for H2A.Z (Krogan et al., 2003; Mizuguchi et al., 
2004; Young, 1991).  As seen in Fig. 4.6 (bottom panels), loss of Swc5 is also 
synthetically lethal in an rpb9Δ background. And, like strains lacking H2A.Z, the first 10 
residues of Rpb9 are essential for viability. This suggests that the Rpb9 N-terminal 
domain, through at least the first 10 amino acids, is related to the presence of H2A.Z in 
nucleosomes specifically.   
These experiments suggest a model in which Rpb9 is part of a common hub for 
pol II-associated factors that are important for negotiation through chromatin. However, 
to our knowledge, the only evidence of direct interaction Rpb9 and any of the four 
proteins above was from a Y2H screen that reported an interaction with Spt7, though it 
is known that the SAGA complex does contact the body of pol II (Wery et al., 2004). 
Additionally, there is no evidence that any of the components of the SWR1 complex, 
including Swc5, contact any subunit of pol II. This could argue that if Rpb9 did act in 
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stabilizing/recruitment/optimal function of the SAGA (Gcn5/Spt7) or SWR1 
(H2A.Z/Swc5), then it does so through an intermediary. Alternatively, it could be that 
Rpb9 N-terminal domain is related to a separate essential pathway that when abrogated 
through deletion of residues 2-11, is lethal when added to the loss of deposition of 
H2A.Z or any of the functions related to the SAGA complex.  
 
Loss of Bye1 has no additive effects with dst1Δ, rpb9Δ, or dst1Δrpb9Δ mutations 
 
One attractive candidate that could serve as a link between Rpb9 and chromatin 
is the protein Bye1. As discussed in the introduction of this chapter, Bye1 has been 
implicated in two functions within pol II-transcribed genes (Pinskaya et al., 2014). The 
first role, which is mediated through its TFIIS-like domain, or TLD, is one in which 
Bye1 binds to pol II that is paused at nucleosomes and displaces TFIIS (Also see Fig. 4.1 
C and D). It has been documented that as elongating pol II encounters nucleosomes, it 
can pause and backtrack, necessitating TFIIS-mediated RNA cleavage for realignment of 
the RNA 3′-end. Subsequent replacement of TFIIS by Bye1 could aide in reactivation of 
transcription which has been previously suggested (Pinskaya et al., 2014). The second 
role is involved with the H3K4 trimethylation-dependent occupancy of Bye1 (through its 
PHD domain) at promoters of pol II-transcribed genes that are normally transcribed at 
low levels, but that can be activated under certain stress conditions. The presence of 
Bye1 is thought to aide in transcriptional activation/initiation at these loci (Kinkelin et 
al., 2013; Pinskaya et al., 2014). If Rpb9 is related to the function or association of Bye1 
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with its binding site on the “jaw” domain of Rpb1, then several predications can be 
made. First, if Rpb9 affects the binding of Bye1 and therefore it’s function while 
localized to pol II, then we would expect that the double knock-out of RPB9 and BYE1 
would not be synthetic lethal. Second, if a portion of Bye1 function is dedicated to 
displacing TFIIS, then dst1∆ (DST1 encodes TFIIS) should be epistatic with bye1Δ 
dst1Δ. Likewise, if the loss of Rpb9 affects Bye1 occupancy and Bye1 affects TFIIS 
occupancy, then dst1Δ rpb9Δ should be epistatic with bye1Δ dst1Δ rpb9Δ. Finally, given 
the proximity of the of the N-terminal domain of Rpb9 to the portion of Rpb1 that binds 
to the Bye1 TLD, there should be mutations in the N-terminal domain that are epistatic 
with bye1∆ if Rpb9 is necessary for Bye1 association, though the subtle phenotypes of 
the loss of Bye1 could be masked by the more severe phenotypes of Rpb9 truncations. If, 
however, mutations in the N-terminal region of Rpb9 are additively negative with the 
loss of Bye1, it could suggest that Bye1 and the N-terminal domain of Rpb9 are related 
in that they support separate pathways that function in parallel or redundantly, or that the 
two suggested functions of Bye1 operate independently and the Rpb9 N-terminal domain 
is only required for one of the two functions.  
In order to explore the interaction between Rpb9 and Bye1, we began by crossing 
a bye1Δ strain into an rpb9Δ background and analyzing by tetrad analysis. As seen in 
Fig. 4.7, the bye1Δ rpb9Δ double mutant is not synthetic lethal and bears the growth 
phenotype of an rpb9Δ alone. To confirm this limiting phenotype of the rpb9Δ in the 
bye1Δ rpb9Δ combination, we challenged strains carrying the double, or either of the 
single gene deletions with various stressors within the growth media. Stress agents  
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Figure 4.7: Isolation of the bye1∆rpb9∆ double mutant 
Figure above is a representative dissection of a resultant tetrad of a cross between a 
yeast strain with RPB9 deleted from the genome via substitution with the HIS3 ORF, 
and a strain with BYE1 deleted via substitution with the KanMX4 cassette whose 
gene product confers resistance to the protein synthesis inhibitor G418. The haploid 
spore containing both gene deletions should be both His+ and G418 resistant 
(indicated by white circle). See Chapter II for further details.  
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included: increased temperature, osmotic stress/cell wall integrity (NaCl and caffeine), 
nucleotide depleting drugs (6-AU and MPA), and an RNA chain terminator 
(Cordycepin). Loss of Bye1 does not elicit any of the phenotypes tested (Fig 4.8). On the 
contrary, in some instances bye1Δ confers a resistance to caffeine and MPA at higher 
concentrations. This is in contrast to rpb9Δ, which confers the well-documented 
hypersensitivity to nucleotide depleting drugs, particularly MPA, even at lower 
concentrations, as well as sensitivity to elevated temperature and caffeine. The  
bye1Δ rpb9Δ strain has phenotypes identical to rpb9Δ, consistent with the idea that the 
function of Bye1 is dependent on the presence of Rpb9.  
It has been reported that deletion of Bye1 increases vegetative growth, consistent 
with the suppression we see for select phenotypes in our own results (though we did not 
observe the same growth increase) (Breslow et al., 2008; Kapitzky et al., 2010). We 
wondered if the resistance to stress seen in bye1Δ strains was related to TFIIS, as 
association with pol II increases under stress conditions (Pinskaya et al., 2014). The 
sensitivity of dst1Δ strains to the various growth conditions is also epistatic with bye1Δ 
(Fig. 4.8). In fact, the triple mutant (bye1Δ dst1Δ rpb9Δ) is only as sensitive as dst1Δ 
rpb9Δ. The additively negative affect of combining rpb9Δ with dst1Δ suggests that there 
are two differential functions of Rpb9 and TFIIS that are related but independent of each 
other, which is in agreement with all the in vivo literature on the double mutant 
(Koyama, 2003, 2007; Koyama et al., 2010). This is also consistent with the literature 
that has shown Rpb9 to affect TFIIS-mediated cleavage (Awrey, 1997; Knippa and 
Peterson, 2013). The epistasis we observed with the loss of Bye1 and the deletion of  
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presence of Bye1 is thought to aide in transcriptional activation/initiation at these 
loci (Kinkelin et al., 2013; Pinskaya et al., 2014). If Rpb9 is related to the function or 
association of Bye1  
 
 
 
 
Figure 4.8: Selected stress phenotypes of combinations of bye1Δ, dst1Δ, and rpb9Δ 
Ten-fold spot dilutions on rich media of haploid yeast strains carrying the indicated 
gene deletion created via PCR mediated gene disruption as described in Chapter II. 
Temperature and chemical phenotypes of varying concentration are indicated above 
each panel. All picture are shown after 2 days of growth except for the caffeine 
phenotype which is after 5 days of growth.   
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RPB9, DST1, or both, suggests that there could be a co-dependence of Bye1 on the 
presence of both Rpb9 and TFIIS. Alternatively, it may be that Bye1 is completely 
unrelated to the action of Rpb9 and TFIIS and the demonstration of epistasis is because 
BYE1 is a redundant non-essential gene. This, however, is much harder to rationalize 
given the bona fide effects of the bye1Δ in vivo and in vitro.  
 
Overexpression of Bye1 does not suppress phenotypes of dst1Δ or rpb9Δ strains   
 
 As noted earlier, Bye1 has been suggested to have a bi-modal function in the cell. 
In addition, over expression of Bye1 has been shown to increase sensitivity to 6-AU, 
similar to the deletion of DST1, which suggests the existence of a competition between 
Bye1 and TFIIS for pol II binding (Wu et al., 2003). If the functions of Bye1, both at 
promoters of genes and during transcription through nucleosomes, are dependent solely 
on its ability to interact with pol II, and Rpb9 and/or TFIIS modulate these interactions, 
then it might be expected that overexpression of Bye1 in the absence of either TFIIS or 
Rpb9 would modulate the phenotypes of both a dst1Δ and rpb9Δ. Alternatively, the two 
suggested functions of Bye1 may operate independently, and altering the association of 
Bye1 with transcribing pol II may not necessarily affect its ability to operate at 
promoters. In addition, if Bye1 displaces TFIIS, overexpression of Bye1 may make no 
difference in the context of dst1Δ or rpb9Δ. To address this, we constructed over-
expression plasmids containing wild-type BYE1, RPB9, DST1 (TFIIS), or a cleavage 
deficient variant of DST1 (TFIIS E291N), and transformed them in combinations with  
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Figure 4.9: Overexpression of Bye1, Rpb9, or TFIIS, and rpb9 N-terminal mutants 
in combination with bye1Δ, dst1Δ, or rpb9Δ backgrounds on MPA 
Ten-fold spot dilutions of haploid yeast strains carrying the indicated gene deletion 
and plasmid combination (pRpb9—Rpb9 variants, pBye1— BYE1, pDst1—DST1 or 
dst1-E291N). Rpb9 N-terminal mutants, BYE1, DST1, or the cleavage-null dst1 
mutant were cloned into a centromeric plasmid (WT), as well as a high copy number 
2μ plasmid (OE) , and transformed into the indicated background strain (indicated by 
brackets surrounding what is contained on the vector). Pictures are shown after 3 
days of growth.  
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Figure 4.10: Overexpression of Bye1, Rpb9, or TFIIS, and rpb9 N-terminal mutants 
in combination with bye1Δ, dst1Δ, or rpb9Δ backgrounds on caffeine or hydroxyurea 
Ten-fold spot dilutions of haploid yeast strains carrying the indicated gene deletion 
and plasmid combination (As in previous figure). Pictures are shown after 3 days of 
growth on minimal media containing caffeine or hydroxyurea.  
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bye1Δ, dst1Δ or rpb9Δ. As seen in Figs. 4.9 and 4.10 (3rd, 6th, and 7th rows of panels), 
overexpression of Bye1 does not exacerbate or suppress any phenotype in the dst1Δ or 
rpb9Δ backgrounds. Nor does the overexpression of the cleavage inactive dst1 mutant. 
Much like the behavior observed in Fig. 4.8, only wild-type Rpb9 or TFIIS can restore 
the growth defect of the bye1Δ rpb9Δ or bye1Δ dst1Δ, respectively (Figs. 4.9 and 4.10, 
3rd and 6th row of panels). However, the absence Rpb9 and TFIIS is limiting in every 
phenotype both in the dst1Δ rpb9Δ (compared to dst1Δ or rpb9Δ alone) double mutant, 
and bye1Δ dst1Δ rpb9Δ triple mutant (Figs. 4.9 and 4.10, bottom row of panels), with 
overexpression of wild-type Rpb9 having the greatest suppression of the growth defects, 
sensitivity to MPA, caffeine, and the DNA synthesis inhibitor hydroxyl urea (HU).
 These results provide several interesting conclusions. First, if both Bye1 and 
TFIIS’s occupancy of pol II is mutually exclusive and Bye1 functions at the polymerase 
is solely to displace TFIIS, then we would expect a.) Deletion of BYE1 would be 
epistatic to a dst1Δ rpb9Δ double mutant b.) overexpression of Bye1 alone would mimic 
some of the phenotypes of a dst1Δ, and c.) overexpression of Bye1 in a dst1Δ 
background would have no additional effect on the resulting phenotype. Published 
findings (Pinskaya et al., 2014; Wu et al., 2003) and Figs. 4.8-4.10 are in agreement with 
this model. Second, we also observed that overexpression of Bye1 did not enhance the 
phenotype of a strain lacking Rpb9, suggesting that displacing TFIIS by Bye1 is 
dependent on the presence of Rpb9. Lastly, in a bye1Δ background, overexpression of 
the cleavage deficient E291N mutant of TFIIS could not suppress sensitivity to any of 
the phenotypes tested suggesting that the defect observed through loss of TFIIS through 
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deletion or potentially through displacement by Bye1, relates to the cleavage function of 
TFIIS. However, more direct experiments are needed to explore the specific interaction 
between TFIIS (E291N) and Bye1, as bye1Δ may also suppress some of the phenotypes 
of the cleavage deficient mutation.  It is important to note that these experiments seem to 
relate more to the effect of Bye1 on the function of TFIIS, rather than function(s) of 
Bye1 that may be independent of but important for pol II.  
 
Mutations in the N-terminal domain of Rpb9 are more sensitive to stress in combination 
with bye1Δ 
 
 Experiments up to this point seem to hint at a model where Bye1 competitively 
affects TFIIS occupancy, and Bye1 association could be affected by Rpb9. We also saw 
that Rpb9 interacts with a general class of pol II associated factors relating to chromatin 
via its first ~ 16 amino acids. We wondered if, like the SAGA or H2A.Z factors, Bye1 
also interacted with Rpb9 via this N-terminal domain. To test this, we looked at the 
effect of Rpb9 N-terminal mutations or truncations in a bye1Δ background. If the Rpb9 
N-terminal domain is important for the interaction with Bye1, then we might expect that 
N-terminal mutations of Rpb9 would be epistatic with the loss of Bye1. Alternatively, if 
N-terminal Rpb9 mutations are additively negative with the loss of Bye1, it would argue 
that the defect that we see with the loss of Rpb9 in the context of Gcn5, H2A.Z, Spt7, 
Swc5, is distinct from the defect caused by the loss of Rpb9 in a bye1Δ. In addition, it 
would also argue that the region critical for the Rpb9/Bye1 interaction resides in the C-
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terminal region of Rpb9. All the Rpb9 N-terminal variants tested have no growth defect 
on minimal media (Figs. 4.9 and 4.10 (2nd row of panels)). However, the truncation 
variants (2-6)Δ and (2-16)Δ show a hypersensitivity to MPA at low concentrations, as 
well as a sensitivity to HU. The scanning mutations (14-16)A and (30-31)A also 
demonstrate a slight sensitivity to HU and MPA, respectively. If Rpb9 affects the 
association/function of Bye1 via its N-terminal domain, we might have expected 
resistance in the phenotypes tried, as seen in the bye1Δ only (Refer to Fig. 4.8). But, here 
we do not. Indeed, when we combine these Rpb9 variants with a bye1Δ we see the strain 
becomes additively more sensitive to the drugs or growth conditions tested, especially 
the (2-16)Δ truncation (Figs. 4.9 and 4.10, 4th row of panels). What is interesting is that 
the more conservative mutation in Rpb9 (14-16)A also demonstrates an additive 
phenotype with the loss of Bye1. It would interesting to know whether these residues are 
important for Rpb9 interactions with SAGA or SWR1 complex components as well as 
their behavior with over-expression of Bye1. Taken together however, these results 
suggest that again the C-terminal domain of Rpb9 is important for the interaction of 
Bye1. A potential relationship between Bye1, the Rpb9 C-terminal domain, and TFIIS 
will be discussed in the section bellow.  
 
Discussion 
 
 The small, non-essential subunit Rpb9 has been implicated in several functions 
of eukaryotic RNA polymerase II. More recently, clear biochemical evidence has given 
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insight into Rpb9’s role in error detection by slowing the extension of a mismatched 
base, proofreading through enhancement of TFIIS-mediated cleavage, and modulation of 
the TL dynamic through the so-called Anchor Loop and Rpb9’s C-terminal domain as 
described in Chapter III (Knippa and Peterson, 2013). However, much has been left 
unexplained about all the other non-polymerase interactions that are not necessarily 
related to the C-terminal Zn2 domain of Rpb9, or the active site of pol II. Table 4.1 
illustrates a collection of the interacting proteins that are synthetic lethal upon deletion of 
RPB9, meaning that they are potentially critical in the same functional pathway. At a 
glance, none of the listed proteins or complex components seems to lend itself to a clear 
link to Rpb9. One thing many of them have in common is that they are important for pol 
II navigating chromatin templates, and, in some instances, as with the SAGA complex 
and its component proteins, affect the pol II CTD phosphorylation state, which is 
important for recruitment of various factors that mature the nascent RNA as pol II 
transitions from the 5’- to the 3’- end of the gene (Wyce et al., 2007).   
 To better understand these interactions between Rpb9 and these chromatin-
related complexes, as well as all the synthetic lethal interactions in general, we analyzed 
a subset of them in the context of mutations in Rpb9 that spanned the majority of the 
length of the protein. Interestingly, we found that the N-terminal domain is required for 
cell viability in combination with deletion of GCN5, HTZ1, or SPT7. In addition, 
depending on the stress introduced, C-terminal mutations in Rpb9 behaved differently in 
the absence of SAGA complex components compared to the histone H2A variant, 
H2A.Z. For the deletion of the SAGA complex components, we observed epistasis with 
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the Rpb9 (95-97)A variant which we have shown to be transcriptionally fast. This is in 
contrast to the loss of H2A.Z, which is additively negative with this variant of Rpb9. 
This argues that the function of the SAGA complex is potentially dependent on both the 
function of the N-terminal domain as well as the catalytic role of Rpb9’s C-terminal 
domain. Whereas the Rpb9-dependent function of H2A.Z may be limited to the N-
terminal domain only. Interestingly, disrupting the SAGA complex via deletion of Spt7 
or specifically deleting the histone acetyltransferase activity through Gcn5, yields the 
same outcome. Given that the loss of Gcn5 does not destabilize the SAGA complex as a 
whole (Grant et al., 1997; Sterner et al., 1999), it suggests that the defect caused by 
abrogating the SAGA complex or the N-terminal domain of Rpb9, relates to the histone 
acetyltransferase activity of the SAGA Complex. Upon further analysis, we found that 
the first ~11 amino acids of Rpb9’s N-terminal domain were absolutely required for cell 
viability for the initial three synthetic lethal genes tested. In addition, we also identified a 
new synthetic lethal gene, SWC5. Similar to the relationship between the catalytically 
active component of the SAGA complex Gcn5 and the structural component Spt7, we 
found that the absence of Swc5, an integral component of the SWR1 complex which 
functions to substitute H2A for H2A.Z (Mizuguchi et al., 2004), was equivalent to the 
loss of H2A.Z and also dependent on the first ~11 amino acids of Rpb9. This suggests 
that the defect caused by the absence of H2A.Z or the Rpb9 N-terminal domain, is 
related to the presence of H2A.Z in chromatin.  
 Recent literature on Bye1, a protein with a pol II binding domain very similar to 
that of the transcription factor TFIIS, provided us a testable hypothesis of how Rpb9 
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might directly interact with chromatin, as none of the synthetic lethal genes analyzed 
had. Bye1 contains a TFIIS-like domain that is required for its association to pol II, as 
shown in a recent crystal structure and in vivo studies (Kinkelin et al., 2013; Pinskaya et 
al., 2014). Interestingly, in addition to its ability to bind the polymerase, it has been 
implicated in both the induction of stress-response genes by binding to tri-methylated 
histones at their promoters, as well as a proposed function in displacing TFIIS in order to 
promote productive transcription (Pinskaya et al., 2014).  Given its location proximal to 
the N-terminal domain of Rpb9 (Refer to Fig. 4.1C), we wondered if Bye1 association 
could be affected by the loss of Rpb9 or TFIIS. Our initial experiments (Figs. 4.8-4.10) 
allowed us to make several interesting observations. First, in addition to not being 
synthetically lethal with rpb9Δ, deletion of BYE1 does not result in enhancement of any 
of the phenotypes we tested. Rather, we found that absence of Bye1 made cells more 
resistant to stress in some cases. One possible interpretation of this observation is based 
on the proposed action of Bye1 in displacing TFIIS. TFIIS is preferentially enriched at 
genes under stress conditions (Pokholok et al., 2002). Increasing TFIIS occupancy at pol 
II by eliminating the competition with Bye1 could render cells more resistant to stress. 
This is in agreement with published observations in which overexpression of Bye1 
renders cells more sensitive to 6-AU, and deletion of Bye1 leads to increased growth in 
the presence of 6-AU (Breslow et al., 2008). However, here we did not observe any 
effect of Bye1 over-expression on the MPA sensitivity of rpb9Δ or dst1Δ strains, but we 
have not examined Bye1 over-expression in other genetic backgrounds. The subtle 
phenotypes observed for the bye1Δ are completely dependent on the presence of TFIIS 
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and Rpb9. Indeed, over expression of Bye1 in either a dst1∆ or rpb9∆ background had 
no effect on sensitivity to MPA, Caffeine, or HU. Lastly, combining the N-terminal 
mutants of Rpb9 with bye1Δ were additively negative when compared to either single 
mutant. Specifically, the truncation Rpb9 (2-16)Δ and the scanning mutation Rpb9 (14-
16)A demonstrated the largest increase in phenotype. These results imply that it is the C-
terminal and/or the linker, and not the N-terminal domain of Rpb9 that is potentially 
important for Bye1 association with pol II. It also argues that the mechanism of Rpb9 
and Bye1, however related to chromatin template navigation, is distinct from the 
pathways for which the N-terminal portion of Rpb9 is critical. 
 
Model for Rpb9/Bye1 interaction 
 
 Nucleosomes provide a natural barrier to transcription. One of the proposed 
functions of Bye1 is to locate to pol II via interaction with trimethylated H3K4 in a 
nucleosome. This is done in order to displace TFIIS which has localized to pol II in 
response to the stalling of pol II at the nucleosomal barrier (Kireeva et al., 2005).  It has 
been suggested that displacing TFIIS, which functions to cleave and realign the 3’-end 
of the RNA, allows the TL to gain access to the active and resume productive 
elongation. In addition, it has been shown that the loss of Rpb9 affects TFIIS-mediated 
cleavage without affecting TFIIS binding (Awrey, 1997). Crystal structures containing 
TFIIS bound to pol II show that the TL and domain III of TFIIS, which contains the 
acidic residues essential for RNA cleavage activity, cannot concomitantly occupy the 
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active site (Kettenberger et al., 2004). Quench-flow kinetic analysis has shown that the 
absence of Rpb9 increases nucleotide sequestration at the active sight, consistent with 
the idea that Rpb9 functions, at least in part, by delaying TL closure (Walmacq et al., 
2009). The evidence presented in Chapter III that the effect of Rpb9 on TL closure is 
mediated through its C-terminal domain and the AL of Rpb1, as well as the preliminary 
results from this chapter, are consistent with a model in which Rpb9 can affect TFIIS 
function in two different ways. The first way would be through the AL-TL interaction. 
Rpb9 in this case would function to delay the closure of the TL, which would reduce the 
competition between the TL and TFIIS for active site occupancy and enhance TFIIS-
mediated cleavage. The second component of the model would be that Rpb9 is required 
for efficient Bye1 association with pol II, which competes with TFIIS for pol II 
occupancy. This would negatively affect proofreading, but balance the competition 
between the TL and TFIIS. 
This model makes a number of predictions that could be tested in future 
experiments. Mutations in the C-terminal area of Rpb9 should have phenotypes similar 
to bye1Δ. Indeed, we have observed MPA resistance in some mutations of the C-
terminal domain, which would be consistent with constitutive IMD2 expression (Fig. 
3.2). This effectively would increase the allowed binding of TFIIS, and perhaps 
exacerbate the effect of the TFIIS E291N mutation. In addition, if the AL affects the 
dynamic of the TL, then mutations in the AL would also increase the competition 
between the TL and domain III of TFIIS, providing a second mode for Rpb9 to affect 
TFIIS function at the pol II active site. A similar mechanism has been proposed between 
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GreA/B and the TL in bacteria (Dangkulwanich et al., 2014; Roghanian et al., 2011). 
With our predictions based on this model, experiments with combinations of mutants 
could be performed that look directly at TFIIS occupancy of pol II subject to 
competition with Bye1, as well as experiments that analyze whether mutations in the C-
terminal domain of Rpb9 affect both Bye1 and TFIIS occupancy, given that they bind 
similarly. It may be that the effect of mutating the C-terminal domain of Rpb9 and the 
AL simultaneously affects both Bye1 and TFIIS association, though deletion of all of 
Rpb9 seems to affect cleavage but not association of TFIIS (Awrey, 1997). It would be 
interesting to know whether Rpb9 and Bye1 affect other functions of TFIIS, which 
include formation of the preinitiation complex (Kim et al., 2007), suppressing pausing 
(Schweikhard et al., 2014), and interactions with the SAGA complex through Spt8 and 
the Mediator complex through several subunits (Wery et al., 2004). In addition, it has 
been suggested that the Rpb9 pol III homolog C11, which contains a C-terminal domain 
similar to TFIIS domain III, functions in termination in S. pombe (Iben et al., 2011). It 
would interesting to know if Rpb9 affected termination for pol II through TFIIS 
occupancy. Regardless, the experiments necessary to test this model would be 
straightforward in their approach.   
 
Global model for Rpb9 and transcriptionally related complexes 
 
 The preliminary data with Bye1 and Rpb9 suggest that the Rpb9 N-terminal 
domain is operating in a mechanism distinct from Bye1 and distinct from the function of 
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its C-terminal domain. A study on the pol III Rpb9 homolog C11, showed that several 
conserved hydrophobic residues in the N-terminal Zn2 domain of C11 are important for 
the binding the pol III dimeric termination factor C53/37 (Homologous to Rap30/74 
dimer in humans and a paralogous to pol II TFIIF (Kuhn et al., 2007). These four 
conserved residues reside within the first ~34 amino acids of Rpb9, and three are within 
the first 16 amino acids of N-terminal domain of Rpb9, C11, and the pol I Rpb9 
homolog A12.2 (refer to Fig. 4.11). It is intriguing that several of these residues are 
located within the N-terminal portion of Rpb9 that we have shown to be critical for cell 
viability with the synthetic lethal genes we have analyzed so far. This was exciting given 
that it has been documented that deletion of Rpb9 drastically affects the association of 
TFIIF to pol II (Khaperskyy et al., 2008; Ziegler et al., 2003). Furthermore, a large-scale 
crosslinking/MS study on the association of TFIIF and pol II demonstrated that Rpb9 
crosslinks to the largest subunit of TFIIF (Tfg1) within the first 20 amino acids of the N-
terminal Zn1 domain (Chen et al., 2010). In addition, the analysis also showed that 
regions of Rpb1 and Rpb2 that are adjacent to Rpb9 residues that contact Tfg1, also 
contact Tfg1 and Tfg2. This suggests that Rpb9 N-terminal domain, in combination with 
other core subunits in the local area, provide an interaction surface for the TFIIF 
complex to associate with the body of the polymerase. .  
 TFIIF also has connections with some of the genes whose deletion is synthetic 
lethal with rpb9∆. Of the 22 documented synthetic lethal genes (Table 4.1), 8 also 
physically interact with TFIIF subunits, whether directly or indirectly (Table 4.2). Of 
those, 5 specifically contact the main body of TFIIF through either Tfg1 or Tfg2, and  
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Figure 4.11: Protein alignment of Rpb9 and its pol I and III paralogs 
Sequence alignment of S. cerevisiae Rpb9 homologs C11 and A12 from pol III and 
pol I, respectively. Alignment was generated using ClustalOmega. Asterisks indicate 
complete conservation, colons indicate residue character conservation, and a single 
period indicates residue shape conservation. Highlighted in green is the amino acid 
sequence of Rpb9 and numbers indicate conserved residues important potentially for 
TFIIF (Rpb9) and C53/37 (C11) biding (See text for details).  
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that Rpb1, Rpb4, and Paf1, have been shown to co-immunopurify with Tfg1 or Tfg2 
(Wade and Jaehning, 1996; Wade et al., 1996). In addition, we also noticed that many of 
the synthetic lethal genes from Table 4.2 also interacted with components of complexes 
such as SAGA, Paf1, or SWR1. It is intriguing to consider a model where perhaps TFIIF 
is important for mediating the association or function of these complexes. Given that we 
suspect the N-terminal domain of Rpb9 to affect TFIIF association to pol II, perhaps this 
would provide a molecular link between Rpb9 and these various pol II-associated 
complexes. It has already been demonstrated, through Y2H and various proteomics 
approaches, that the Rpb1 subunit of pol II contacts subunits of TFIIF, as well as SAGA 
and Paf1(Krogan et al., 2002; Lee et al., 2011; Pascual-Garcia et al., 2008). Importantly, 
synthetic lethal genes that contact TFIIF, in some instance contact subunits of every 
complex analyzed. This is in addition to any affects that would be caused by altering any 
functions of TFIIF.   
 This model makes several predictions. If Rpb9 affects the association of TFIIF, 
there should be alleles of TFG1 and TFG2 with phenotypes similar to those of rpb9∆, 
and there are documented alleles of these genes that exhibit MPA sensitivity at 
concentrations that exhibit MPA sensitivity similar to that of rpb9-(2-16)Δ (Jin and 
Kaplan, 2015). In addition, these mutations fall in the area that crosslinks to Rpb9 N-
terminal domain (residues 120-130, 400-420 in Tfg1, and 260-280 in Tfg2) (Chen et al., 
2010). The adjacent areas in Rpb2 (270-280, 340-350) also demonstrate similar 
phenotypes (Kubicek et al., 2013). TFIIF mutants have also been shown to affect start 
site selection, as have mutations in the TL and truncations in the C-terminal domain of 
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Rpb9 (Jin and Kaplan, 2015; Khaperskyy et al., 2008; Shandilya et al., 2012; Sun et al., 
1996; Ziegler et al., 2003). In fact, combinations of upstream start site-shifting TFIIF 
mutations can suppress the downstream defect of downstream shifting TL mutants, and 
exacerbate the defect of upstream shifting mutants (Jin and Kaplan, 2015). Importantly, 
these same TFIIF mutants do not suppress the growth defect of these same start site-
shifting TL mutants. These results argue for a role of TFIIF that is independent of its 
function in start site selection and the TL, perhaps the one we have suggested above 
concerning co-transcriptional complexes.  Nevertheless, we would predict minimally 
that the TL-dependent, C-terminal function of Rpb9 would affect start site selection as 
gain of function TL mutations. However, an additional Rpb9 N-terminal pathway with 
TFIIF may also exist to affect start site selection.  
 In summary, there is compelling evidence that mutations in the lobe region of pol 
II affect TFIIF association. Given that TFIIF interacts with many of the genes that are 
synthetic lethal with Rpb9, we propose that in addition to the defects cause by decreased 
association of TFIIF, decreased association of TFIIF also globally affects the function of 
transcription complexes that temporally associate with the polymerase at all stages of 
transcription, which are depicted Fig. 4.12. If mutations in Rpb9 can alter the interaction 
of TFIIF with pol II, which has a broad range of effects that collectively confer a severe 
growth defect in rpb9∆ strains, it would explain why rpb9∆ has a growth defect more 
severe than that of other fast polymerase mutations. Synthetic lethality results when any 
of a number of processes, already partially disrupted by the absence of Rpb9, is further 
disrupted with a second mutation. This predicts that at least some genes that are 
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synthetically lethal with rpb9∆ should be synthetically lethal with each other in a RPB9 
background, and indeed paf1∆ is synthetically lethal with deletion of several of the 
subunits of SAGA (Ingvarsdottir et al., 2005; Milgrom et al., 2005). This is in contrast to 
the mechanism of Bye1, which seems to be related to the C-terminal function of Rpb9 
and a balanced competition with TFIIS.  
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CHAPTER V 
SUMMARY, FUTURE DIRECTIONS, AND FINAL REMARKS 
  
 The pol II subunit Rpb9, though non-essential, has been shown to be important 
for various functions in the cell, not the least of which is transcriptional fidelity (Knippa 
and Peterson, 2013; Walmacq et al., 2009). Maintenance of accurate transcription is 
critical to faithful conversion of the information stored in DNA into the functional units 
of the cell. Transcriptional fidelity has been a point of much study and in pol II, it seems 
to be governed in part by a mobile domain at the heart of the active site, termed the TL. 
The TL moves in and out of the active site at different stages of the nucleotide addition 
cycle. As discussed in Chapter I, the TL has been implicated in selection of the correct 
substrate base, induction of pausing post-misincorporation, and most notably the balance 
of the catalytic speed of the polymerase which effects both selection and proofreading 
(Kaplan, 2008; Larson et al., 2012; Mejia et al., 2015; Wang et al., 2015; Wang et al., 
2013). Among the other documented phenotypes associated with the loss of Rpb9, it was 
noticed that pol II lacking Rpb9 had similar in vitro behavior to TL mutants which were 
posited to affect the TL transition from the closed position, required for substrate 
addition, to the open position which allows for translocation and another substrate NTP 
to enter the active site (Walmacq et al., 2009). Increasing the trapping of substrates at the 
active site by increasing the fraction of time the TL spends in the closed state can have a 
direct effect on fidelity, and it was proposed that Rpb9 affects fidelity by directly 
affecting the TL transition. However, when this model was tested by measuring the 
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effect on fidelity of a specific mutation in the C-terminal domain of Rpb9, a negative 
result was obtained (Walmacq et al., 2009). This left the specific mechanism of Rpb9 
function, and its relationship to the TL, an open question.   
 One of my initial project goals was to define the role of the TL in Rpb9 function, 
and answer this question. From Chapter III, an approach was used that took advantage of 
the TL inhibitor α-amanitin (Kaplan, 2008). We reasoned that if any of the in vitro 
characteristics of rpb9∆ were dependent on TL movement, then they should be affected 
by the TL immobilization caused by the presence of α-amanitin. Indeed, as seen in 
Chapter III, this was observed to be the case for the increased misincorporation rate for 
pol II∆9, consistent with the idea that in this context, the effect of rpb9∆ was TL-
dependent. In parallel, we were also using a classic genetic approach to elucidate 
functions of Rpb9 by exploiting the rpb9∆ suppressor rpb1-G730D. We were able to 
localize the interaction of this pol II mutant to residues 95-97 in Rpb9. The location of 
these residues in the crystal structures relative to the open conformation of the TL, as 
well as the ability of the rpb9- (95-97)A mutation to phenocopy rpb9∆ both in vivo and 
in vitro, led us to propose a new model of how the Rpb9 C-terminal domain might 
function through the TL.  
 Our new model suggests that it is not a direct interaction by which Rpb9 
stabilizes the open conformation of the TL, but rather an indirect interaction pathway 
way through a loop connecting α-20 and α -21 which we have termed the anchor loop 
(AL). The results in Chapter III demonstrated that mutations that occur on either side of 
an interaction surface between Rpb9 and the AL (rpb9- (95-97)A/rpb1- R711A) or 
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between the AL and TL (rpb1- (707-709A)/ rpb1- S1091C), mimicked properties of 
rpb9∆ in vivo and in vitro. Importantly, these same mutations in the AL and TL were 
epistatic in vitro in combination with rpb9∆, and likewise dependent on TL mobility as 
ascertained through the use of α-amanitin. This suggests that they are in the same 
functional pathway, are upstream defects, and give credence to our model.  
These results are also consistent with molecular dynamic studies that utilized 
published crystal structures (Kireeva et al., 2012; Wang et al., 2013) to model the 
movement of the TL between the open and closed positions. These studies predicted that 
Rpb1 residues E712 (in -21) and K1092 (in the TL), would be important for the TL 
transition (Wang et al., 2013). Indeed, my preliminary in vitro transcription assays 
indicate that E712A is transcriptionally slow (data not shown), which correlates with the 
predicted in vitro phenotype from the molecular dynamics studies. We have also 
examined residues S751 and K752, which are not part of the TL, but do interact with the 
γ- phosphate group of the incoming substrate at the pol II active site and also behave as 
predicted from (Wang et al., 2013). In addition to the residues we have biochemically 
characterized here, it would be beneficial to systematically introduce mutations in the 
AL/ α- 21 helix region based on the observation that mutations in this region can have 
both gain of function and loss of function phenotypes (Wang et al., 2013). Certainly the 
Rpb9 residue S112, which hydrogen bonds with Rpb1-Q698 would be an excellent 
candidate to study, as it also pertains to our model and resides in an area of Rpb9 that 
was missing in a truncated form of Rpb9 that altered transcriptional start site selection 
(TSS) (Sun et al., 1996). As noted in Chapter I, TSS seems to be a common read-out for 
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TL defects. Knowing the effect of all of our rpb9 or AL mutations on TSS would 
generally be useful information to have, given our interpretation of their function.  
In Chapter III, it was also observed that the mutation rpb9- (95-97)A was not 
synthetic lethal with either TL mutants rpb1-E1103G or -L1101S, while the rpb9- (1-59) 
mutation was. As pointed out in the discussion of Chapter III, this could be an indication 
that there are additional functions in the C-terminal domain of Rpb9 beyond the TL-
dependent role we have defined for it. Certainly, one aspect that we have not fully 
addressed is the effect of any of the Rpb9 or AL mutations on the extrinsic cleavage 
factor TFIIS. Indeed, in the crystal structure PDB 1Y1V (Kettenberger, 2003), TFIIS 
spatially is in close proximity to the AL and has a hydrogen bonding interaction at 
residue H706 in Rpb1. It would be interesting to see if, in addition for the role we 
suggest here for the AL, the AL also affects TFIIS function or association. Affecting 
TFIIS occupancy could in addition affect TL occupancy in the active site. This has 
previously been suggested to be the case for the TFIIS bacterial homolog GreA 
(Dangkulwanich et al., 2014; Roghanian et al., 2011).  One simple and straightforward 
experiment would be to over-express TFIIS in the context of the Rpb9-(95-97)A variant 
or any of the AL mutants defined in this work. If the AL or the C-terminal of Rpb9 has 
any effect on TFIIS function we might predict that over expression of TFIIS would 
suppress some of the AL or Rpb9 C-terminal mutant phenotypes.  
It is important to point out that this function of the Rpb9 C-terminal domain on 
TL function distinguishes it from its pol I and III counterparts. As discussed in the 
introduction, both C11 and A12.2, the pol I and III homologs, respectively, have C-
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terminal domains more closely related to domain III of the pol II cleavage factor TFIIS 
(Cramer et al., 2008). This domain of TFIIS is responsible for displacing the TL and 
stimulating cleavage at the active site, as are the C-terminal domains of C11 and A12.2 
(Alic et al., 2007; Kettenberger et al., 2004; Kuhn et al., 2007). From various structural 
studies and experiments from this work, we have shown that the Rpb9 C-terminal 
domain has a novel function in affecting TL mobility, rather than directly stimulating 
cleavage (Kettenberger et al., 2004; Ruan, 2011). This model of how the C-terminal 
domain of Rpb9 functions provides an explanation for the increase in transcriptional 
speed of pol II lacking Rpb9. In addition, as has been suggested for the bacterial 
counterpart of TFIIS (GreA) (Roghanian et al., 2011), we can also suggest a model of 
how Rpb9 C-terminal domain may affect the competition between TFIIS and the TL for 
active site occupancy through the AL. Rpb9, through the AL, would stabilize the open 
TL, which would balance the ability of TFIIS to gain access to the active site. 
Interestingly, it has been reported from our lab that Rpb9 does affect TFIIS-mediated 
transcript cleavage (Knippa and Peterson, 2013). Perhaps these results also reflect this 
balance between transcriptional speed through the TL, and cleavage through TFIIS.  
It is interesting to consider why pol II depends on TFIIS for efficient removal of 
transcription errors, while pol I and pol III contain integral subunits that promote much 
more rapid proofreading (Alic et al., 2007; Kuhn et al., 2007). As described in Chapter I, 
pol I and III transcribe genes that are of limited variety, and, compared to pol II, they 
have a faster rate of elongation (refer to Table 1.1). This faster speed may make it 
advantageous for pol I and polIII to carry an endogenous means of transcript cleavage 
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rather than the remote, slower system utilized by pol II. In addition, in the case of pol III, 
the cleavage activity of C11 is specifically needed for transcription termination (Iben et 
al., 2011). This in contrast to pol II where the variety of templates and promoters might 
demand a more modular approach that would allow different types of regulatory 
molecules to interact with pol II depending on the context. The same argument could be 
made with various mRNAs that require pol II pausing or co-transcriptional processing. 
One specific example of this modular behavior may be present in the apparent 
competition between Bye1 and TFIIS described in Chapter IV, which is discussed 
further below.  
Only within the last ~10 years has the C-terminal domain of Rpb9 been 
suggested to be important for Rpb9 function (Li et al., 2006). This is due in part to the 
original interpretation of MPA sensitivity being linked specifically to elongation rate, 
which for intrinsic TL mutations seems to be the case. However, from our work we see 
two very distinct types of MPA sensitivity derived from mutations in Rpb9, one derived 
from the N-terminal domain, the other from the C-terminal domain. The results shown in 
Fig. 3.3, as well as some reported by others (Hemming et al., 2000; Koyama, 2007; Li et 
al., 2006), have shown that the N-terminal residues [Rpb9- (1-59) in this work] are 
sufficient to suppress many of the growth and drug sensitivity phenotypes associated 
with rpb9∆ strains (which inadvertently makes the identification of C-terminal mutations 
very hard), and that functions of Rpb9 at the pol II active site seem to localize to the C-
terminal domain (Koyama, 2007; Koyama et al., 2010; Li et al., 2006). This, as pointed 
out in Chapter III, makes the MPA sensitivity of rpb9- (95-97)A unique. However, even 
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though the N-terminal domain seems important for many of the phenotypes of rpb9∆, 
currently its mechanistic details remain unclear. Even less is known concerning the 
genetic interactions between Rpb9 and a variety of non-polymerase subunits of 
chromatin modifying complexes (Table 4.1). In Chapter IV, I attempted to elucidate a 
role for Rpb9 in terms of the chromatin modifying complexes, and suggested that they 
seem to be related to the N-terminal domain of Rpb9.  
To probe the question of these genetic interactions between RPB9 and the genes 
in Table 4.1, we asked what structural portion of Rpb9 is able to rescue the synthetic 
lethality associated with the combination of rpb9∆ and the loss of each of these genes. 
We initially began our investigation with HTZ1, SPT7, and GCN5. As seen in Chapter 
IV, the first 59 amino acids of Rpb9 were sufficient to suppress the synthetic lethality, 
suggesting that the N-terminal domain of Rpb9 was important for the function of the 
H2A.Z variant (HTZ1) or SAGA complex components (GCN5 and SPT7). Further 
analysis revealed that C-terminal alterations in Rpb9, specifically the (95-97)A variant, 
differentially interacted with these mutations. In the case of htz1∆ rpb9-(95-97)A mutant 
strain, we observed a double mutant phenotype which was worse than either htz1∆ or 
rpb9- (95-97)A alone on rich media. This might be expected given that the synthetic 
lethality associated with the htz1∆ rpb9Δ double mutant is completely suppressed by the 
Rpb9 N-terminal domain (Rpb9- (1-59)), and that the N- and C-terminal functions of 
Rpb9 seem to be separable. In addition, deletion of SWC5, which encodes a structural 
component of the SWR1 complex, responsible for insertion of H2A.Z into nucleosomes, 
was similarly lethal with the loss of Rpb9. This lethality could also be rescued by the 
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presence of Rpb9- (1-59) and suggests that the interaction of Rpb9 with H2A.Z depends 
on the presence of H2A.Z in the nucleosome. The combination of gcn5∆ or spt7∆ with 
C-terminal rpb9 mutants in contrast, were epistatic in some phenotypes, suggesting that 
any function of Rpb9 that is SAGA complex related may also be related to 
transcriptional speed and/or some other function of the Rpb9 C-terminal domain. As 
discussed previously, the interaction of Rpb9- (95-97)A and TFIIS, which directly 
interacts with the SAGA component Spt8 (Wery et al., 2004), remains unstudied. In 
addition, it would be interesting to know whether any component of the SWR1 complex 
makes contacts through Rpb9 directly. Perhaps this could be assayed initially through a 
Y2H screen.  
N-terminal deletions in Rpb9 suggested that the first 11-16 amino acids are 
critical for cell viability in the absence of the selected chromatin-related genes. These 
residues localize to the same spatial region of the Rpb9 N-terminus, suggesting that there 
may be an intermediary that interacts with this region to allow communication between 
pol II (through the N-terminal domain of Rpb9 on the leading edge of the polymerase) 
and nucleosomes. One primary candidate for this intermediary is the transcription factor 
Bye1. Bye1 had been previously shown to bind to pol II through a TFIIS-like binding 
domain, which is unique given that it is the only other known protein in yeast which has 
this domain (Kinkelin et al., 2013; Pinskaya et al., 2014). Structurally, Bye1 contains a 
histone binding motif (PHD domain) and a less understood protein binding domain 
(SPOC domain). A recent crystal structure of Bye1 with pol II (Kinkelin et al., 2013), 
showed that Bye1 binds the Rpb1 jaw domain just above the N-terminal domain of 
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Rpb9, suggesting Rpb9 may affect Bye1 association with the polymerase and impact the 
progression of pol II through chromatin templates.  
Preliminary experiments with bye1∆ demonstrated that the mutant phenotype 
was dependent on the presence of either Rpb9 or TFIIS. This is not surprising in terms of 
TFIIS, considering that the occupancy of Bye1 and TFIIS are most likely mutually 
exclusive, and competition for pol II binding between Bye1 and TFIIS has been 
proposed to be a function of Bye1 (Pinskaya et al., 2014; Wu et al., 2003). As pol II 
encounters a nucleosome, stalls, and is reactivated by TFIIS, it has been suggested that 
TFIIS must be displaced so that transcription can resume (Pinskaya et al., 2014). This 
raised the possibility that the competition between Bye1 and TFIIS indirectly affects the 
TL occupancy of the active site, given that domain III of TFIIS inserts into the active 
site, displacing the TL during cleavage (Kettenberger, 2003). This notion is somewhat 
supported by the negative interactions observed in Rpb9 N-terminal truncations in a 
bye1∆ background, and that in the Bye1/pol II crystal structure, the Bye1 TLD domain 
hydrogen bonds with the AL. Experiments that examine the phenotypes of C-terminal 
Rpb9 mutants with bye1∆, as well as directly examining the effect of Rpb9 mutations on 
Bye1 binding to pol II, must be done. In addition, given the suggested competition of 
Bye1 and TFIIS, which may also depend on Rpb9 and/or the AL, it would interesting to 
see how Bye1 and Rpb9 C-terminal mutants affect RNA cleavage in vitro.  
 In addition to the possibility of a communication line between Rpb9 and 
chromatin via Bye1, it has been shown that the pol III Rpb9 homolog (C11) is important 
for association of the pol III termination factor C53/37 (Iben et al., 2011). This 
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termination factor is a paralog of the basal transcription for TFIIF in pol II. More 
importantly, the residues that are important for the hydrophobic binding surface in C11 
are conserved in Rpb9 (and A12.2), three of which fall into the first 20 amino acids of 
Rpb9 (A12.2 as well). This was intriguing as a recent large-scale protein cross-linking 
analysis of a pol II/TFIIF complex revealed contacts between both large subunits of 
TFIIF and the same region of the Rpb9 N-terminal domain (Chen et al., 2010). 
Furthermore it has previously been documented that deletion of Rpb9 virtually 
eliminates TFIIF association with pol II in vitro (Ziegler et al., 2003).  As described in 
Chapter IV, this suggested the possibility that the Rpb9 N-terminal domain (along with 
adjacent residues from Rpb1 and Rpb2) could mediate TFIIF interactions with pol II. 
  If this hypothesis is correct, it has several very important implications. First, if 
the Rpb9 N-terminal domain is important at least in part for TFIIF association, as has 
been suggested for the N-terminal domain of C11, then it could provide a link between 
the global association hub that is pol II, and many chromatin modifying complexes. 
These complexes, as pointed out in Chapter IV, either directly interact with TFIIF (Paf1) 
or are dependent on some upstream signal mediated by the presence of TFIIF at pol II 
(Rad6/Bre1).  Second, Rpb9 could have an alternate pathway to modulate pol II catalytic 
activity given that TFIIF by itself, or synergistically with TFIIS, can affect the passage 
of pol II through pause sites and nucleosomal barriers, which is important for 
transcription efficiency (Ishibashi et al., 2014; Schweikhard et al., 2014). Lastly, TFIIF 
has been suggested to have a TL-independent role in TSS selection (Jin and Kaplan, 
2015), perhaps providing a secondary path for Rpb9 to affect the selection of a TSS. 
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Certainly, there is evidence for this model already, as a study in which it was found that 
Rpb2 mutations in the area adjacent to the Rpb9 N-terminal domain residues that may be 
important for TFIIF binding, phenocopy certain TFIIF mutants which are deficient in pol 
II association (Kubicek et al., 2013). It will be very important for our lab to look at 
TFIIF/Rpb9 mutant combinations in the near future to test this model, which is 
important given its global implications in co-transcriptional pol II-associated complexes. 
If the Rpb9 N-terminal domain does affect TFIIF association, we could initially probe 
this by over-expressing both subunits of TFIIF in yeast (Tfg1/2) and observe whether or 
not the over-expression could suppress any of the phenotypes we have observed in the 
N-terminal domain of Rpb9. We could also couple these simple in vivo experiments with 
more detailed biochemical tests that observe TSS, such as a primer extension assays. 
This would allow us to observe whether or not the N-terminal domain can affect start 
site selection through a TL/Rpb9 C-terminal domain independent pathway.  
In closing, presented above are potential future directions for the pol II subunit 
Rpb9. This body of work has described a role of the C-terminal domain in terms of the 
mobile active site domain, the TL. It will be interesting to see the forward progress of 
research on Rpb9, given the relatively minimal collection of data on its N-terminal 
structural functions. Four our lab, Rpb9 has been a remarkable tool to look into the 
function of pol II. Because it is non-essential, we can study the changes induced in pol II 
by its absence. In addition, we have seen that it reports on at least two different types of 
interactions—those in the active site, and those on the exterior of pol II. My hope is that 
this body of work has conveyed the significance of Rpb9 in the context of pol II.  
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APPENDIX 
 
 
 
 
  
 
 
 
 
 
  
Yeast strains lacking genomic RPB1 and RPB9 are supplemented with RPB1 on a 
URA3 marked plasmid. Strains are then transformed with varying alleles of RPB1 
with mutations in various areas of the TL on a LEU2 marked plasmid. If selected TL 
mutations are lethal with the loss of Rpb9, then cells with be forced to maintain the 
RPB1 CEN URA3 plasmid. Plating of these cells to 5-FOA will then result in cell 
death.   
Figure A.1: Interactions of Trigger Loop mutants and rpb9Δ 
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 (A) The EC complex with template/non-template DNA combinations used for 
misincorporation assay as well as the pre-annealed 5’-32P labeled RNA (red) as in Fig. 
3.1. (B)  ATP 1mM was added to ECs immobilized from WCEs with pol II, rpb1-
G730D pol II, pol II∆9, or rpb1-G730D pol II∆9, and the extension of the RNA to 11 
nucleotides (nt) or greater was monitored over time via a 20% polyacrylamide gel. 
The rpb1 mutation was introduced into cells as in Appendix Fig. 1. (C and D)The 
fraction extended to 11 or greater nts in B was plotted and fit to a single exponential 
function to obtain an observed rate for misincorporation, indicated by each curve. The 
fraction elongated was divided by the extent of the reaction as determined by curve 
fit.  
Figure A.2: The effect of the rpb1- G730D mutation on the pol IIΔ9 
misincorporation rate. 
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 Rpb9 or Rpb9- (95-97)A with an N-terminal 6X-His and Flag-epitope tag was 
expressed as described in the methods chapter in a pET28a vector bacterial 
expression system. Lysates in varying amounts (post-induction with IPTG) derived 
from bacteria with vector only, or expressing recombinant Rpb9 were added to Ni2+ -
 
NTA beads and probed with an α-Flag antibody to determine success of expression. 
Bracketed at the bottom of both panels is the strains loading of each lane. (In.) 
indicates crude lysate, while (PD) indicates lysate added to beads. The top panel 
shows the Panceau (2mg/mL in 1% acetic acid) stained nitrocellulose membrane after 
transfer from SDS PAGE. Standard band sizes are indicated on the left.  Bottom panel 
is the resulting Western blot with a strong band approximately ~14kDa which 
corresponds to the size of recombinant Rpb9. The faster migrating band below are 
degradation products.  
Figure A.3: Bacterial expression of wild-type and the (95-97)A variant of Rpb9 for 
purification 
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Lysates of bacteria expressing Rpb9 or Rpb9- (95-97)A were added to a His-Trap FF 
Crude column and washed in imidazole gradients as described in materials and 
methods. Final elution concentration corresponds with appearance of a protein band 
the approximate size of Rpb9 (blue arrow) as detected by a Coomassie stained SDS 
PAGE gel.   
Figure A.4: Initial purification steps and elution profile of recombinant Rpb9 from 
bacterial lysates. 
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Fractions from His-Trap FF column were pooled and applied to a 30kDa cut-off 
spinal column. Flow-through was then added to a 10kDa cut-off spin column and 
concentrated to 500 μL volume and analyzed by Western which demonstrated a single 
band of a size approximate to Rpb9 that is also detected by an α-Flag probe.  
Figure A.5: Final purification step of Rpb9 or Rpb9- (95-97)A purification 
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Purified recombinant Rpb9 or Rpb9- (95-97)A was added back to ECs immobilized 
from WCEs derived from strains with pol II lacking Rpb9 and/or the rpb1-G730D 
mutation in amounts 20 times the published KD. Preparation of ECs was identical to 
that of Fig. 3.1 except that we found an addition wash of 0.035% Sarkosyl was 
necessary for assembly. (A) ATP 1mM was added to indicated ECs and the extension 
of the RNA to 11 nucleotides (nt) or greater was monitored over time via a 20% 
polyacrylamide gel. (B and C)The fraction extended to 11 or greater nts in A was 
plotted and fit to a single exponential function to obtain an observed rate for 
misincorporation. Indicated on the graphs are the average rates in each grouping (i.e, 
pol IIΔ9 and Rpb9- (95-97)A + pol IIΔ9 have a kobs ~0.10 min-1, while pol II (WT), 
Rpb9 + pol IIΔ9, and rpb1-G730D pol IIΔ9 all have a kobs ~0.05 min-1).  
Figure A.6: Misincorporation rate of pol II ECs reconstituted by addition of 
purified Rpb9, or Rpb9- (95-97)A 
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10-fold serial dilutions of indicated Rpb9 mutations. Performed as in Fig. 3.7.   
Figure A.7: GalS phenotype of selected RPB9 C-terminal mutations rpb9- Q87A/-S96A 
10-fold serial dilutions of indicated AL-TL mutations as described in Chapter III. 
Cells were spotted from saturated liquid culture on the indicated media and monitored 
for growth for the indicated days. Performed as in Fig. 3.7, Rpb1 mutations where 
derived from shuffles as described in materials and methods and Fig. A1.   
Figure A.8: Selected phenotypes of mutations at the AL-TL interface 
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 10-fold serial dilutions of indicated AL-TL mutations as described in Chapter III. 
Identical strains and preparation to Fig. A8 and Fig. 3.7.   
Figure A.9: GalS phenotypes of mutations at the AL-TL interface 
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 Figure A.10: Average correct nucleotide extension rate of Rpb9, AL, and TL 
mutants 
The EC complex with template/non-template DNA combinations used to determine 
the average correct nucleotide extension rate as in Fig. 3.2 except that ECs were 
assemble from WCEs rather than purified pol II. A-, C,-, G, and UTP 1mM were 
simultaneously added to ECs derived from strains with indicated pol II mutation. The 
fraction of RNA extended to 61 nt (forming a product of 51nt) was plotted and fit 
with a non-linear equation to determine the half-time. The extension rate in nt/s was 
determined by dividing the 25 nts by the half-time and is indicated below each 
representative gel. (A) Estimation of the correct nucleotide extension rate for the 
Rpb9 variant, Rpb9- (95-97)A. (B) Estimation of the correct nucleotide extension rate 
for the AL mutations rpb1- (707-709)A and -R711A, as well as the TL mutation rpb1-
S1091C.  
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Complexes were formed as described in Fig. 3.4. ATP 1mM was added to ECs with 
indicated pol II mutation alone or ECs pre-incubated with α-amanitin, and the 
extension of the RNA to 11 nucleotides (nt) or greater was monitored over time via a 
20% polyacrylamide gel. The fraction extended to 11 nts was plotted and fit to a 
single exponential function to obtain an observed rate for misincorporation, indicated 
by each representative in vitro assay and compiled in Table 3.1. 
Figure A.11: The rate increase for an ATP misincorporation caused by mutations 
in the AL is dependent on α-amanitin 
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The EC complex with template/non-template DNA combinations used to determine 
the average correct nucleotide extension rate as in Chapter III, Fig. 2 except that ECs 
were assemble from WCEs rather than purified pol II. A-, C,-, G, and UTP 1mM 
were simultaneously added to ECs derived from strains with indicated pol II mutation 
that were pre-incubated with α- amanitin for 15 minutes. The fraction of RNA 
extended to 34 nts or greater for α-amanitin experiments was plotted and fit with a 
non-linear equation to determine the half-time. The extension rate in nt/s was 
determined by dividing the length of the extension product n- nucleotides long by the 
half-time. Elongation rates are indicated below each representative gel and compiled 
in Table 3.1 
Figure A.12: Average correct nucleotide extension rate of Rpb9, AL, and TL 
mutants in the presence of α- amanitin 
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Shuffles performed as in Fig. A1. See Chapter III for description.    
Figure A.13: Interactions of Trigger Loop mutants, rpb1- L1101S and - E1103G 
with rpb9- (1-59) and - (95-97)A 
